Player FM - Internet Radio Done Right
45 subscribers
Checked 6d ago
تمت الإضافة منذ قبل nine عام
المحتوى المقدم من DeviceTalks. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة DeviceTalks أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
S
Squid Game: The Official Podcast
Squid Game is back, and so is Player 456. In the gripping Season 2 premiere, Player 456 returns with a vengeance, leading a covert manhunt for the Recruiter. Hosts Phil Yu and Kiera Please dive into Gi-hun’s transformation from victim to vigilante, the Recruiter’s twisted philosophy on fairness, and the dark experiments that continue to haunt the Squid Game. Plus, we touch on the new characters, the enduring trauma of old ones, and Phil and Kiera go head-to-head in a game of Ddakjji. Finally, our resident mortician, Lauren Bowser is back to drop more truth bombs on all things death. SPOILER ALERT! Make sure you watch Squid Game Season 2 Episode 1 before listening on. Let the new games begin! IG - @SquidGameNetflix X (f.k.a. Twitter) - @SquidGame Check out more from Phil Yu @angryasianman , Kiera Please @kieraplease and Lauren Bowser @thebitchinmortician on IG Listen to more from Netflix Podcasts . Squid Game: The Official Podcast is produced by Netflix and The Mash-Up Americans.…
J&J's John Murray and Dr. Kerber on neurovascular innovation and lessons in imagination & resilience
Manage episode 459836538 series 100901
المحتوى المقدم من DeviceTalks. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة DeviceTalks أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
In this episode of Neuro Innovation Talks, host John Murray interviews Charles "Chuck" Kerber, MD, Emeritus Professor of Radiology and Neurosurgery at UCSD, a pioneering force in neurovascular medicine, whose innovations—such as flow-directed catheters and cyanoacrylates for therapeutic embolization—transformed the field. Dr. Kerber reflects on his Appalachian roots and military experience, highlighting how these influences shaped his views on responsibility, mentorship, and patient-centered care. His philosophy of innovation, grounded in imagination and resilience, offers a blueprint for tackling complex medical challenges. The discussion explores the iterative process of developing life-saving neurovascular devices, from early failures to groundbreaking successes, and emphasizes the vital role of collaboration with industry partners. Dr. Kerber shares stories of his mentorship style, which encouraged creativity and accountability, and its profound impact on the next generation of neurovascular physicians. He also underscores the importance of ethical considerations and humanity in patient care. Looking ahead, Dr. Kerber advocates for the continued integration of creativity and teamwork in addressing future neurovascular challenges. He closes by offering young physicians advice on embracing imagination and perseverance to drive innovation and improve patient outcomes. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Eytan Raz, MD, Boris Pabon, MD, Joseph Horton, MD, John Barr, MD, and special thanks to William Bank, MD. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!
…
continue reading
370 حلقات
J&J's John Murray and Dr. Kerber on neurovascular innovation and lessons in imagination & resilience
Manage episode 459836538 series 100901
المحتوى المقدم من DeviceTalks. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة DeviceTalks أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
In this episode of Neuro Innovation Talks, host John Murray interviews Charles "Chuck" Kerber, MD, Emeritus Professor of Radiology and Neurosurgery at UCSD, a pioneering force in neurovascular medicine, whose innovations—such as flow-directed catheters and cyanoacrylates for therapeutic embolization—transformed the field. Dr. Kerber reflects on his Appalachian roots and military experience, highlighting how these influences shaped his views on responsibility, mentorship, and patient-centered care. His philosophy of innovation, grounded in imagination and resilience, offers a blueprint for tackling complex medical challenges. The discussion explores the iterative process of developing life-saving neurovascular devices, from early failures to groundbreaking successes, and emphasizes the vital role of collaboration with industry partners. Dr. Kerber shares stories of his mentorship style, which encouraged creativity and accountability, and its profound impact on the next generation of neurovascular physicians. He also underscores the importance of ethical considerations and humanity in patient care. Looking ahead, Dr. Kerber advocates for the continued integration of creativity and teamwork in addressing future neurovascular challenges. He closes by offering young physicians advice on embracing imagination and perseverance to drive innovation and improve patient outcomes. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Eytan Raz, MD, Boris Pabon, MD, Joseph Horton, MD, John Barr, MD, and special thanks to William Bank, MD. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!
…
continue reading
370 حلقات
كل الحلقات
×1 Why proven MedTech inventor and CEO Daniel Hawkins sees a huge opportunity in AI-powered MRIs 53:42
53:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
53:42In this episode of the DeviceTalk Weekly podcast, Host Tom Salemi talks with MedTech legend Daniel Hawkins, a serial entrepreneur who has a hand in many industry success stories. He was employee number six at Intuitive before setting out on a path of innovation, developing the technologies around companies like Shockwave Medical. More recently, Hawkins was CEO of Avail Medsystems, the presumed leader of the pack of companies trying to redefine OR communications, but that company shuttered last year when it couldn’t raise additional capital. Today, Hawkins is leading Vista.ai, which is selling an AI-enabled package that makes it much easier for MRI technologists to capture meaningful images of the heart. Hawkins sees Vista.ai as improving patient care while also helping imaging centers address the crushing shortfall of experts. This episode is sponsored by DeviceTalks Boston. Register to attend our April 30-May 1 event of the year at Boston.Devicetalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss out on a future episode.…
1 Boston Scientific’s Brad Sutton explains why FARAPULSE may be part of the best story in MedTech 1:02:30
1:02:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:30In this episode of the DeviceTalks Weekly Podcast, we get an inside look into why Boston Scientific’s AF Solutions division has experienced such a meteoric rise over the past few years. CMO Dr. Brad Sutton lays out the problem facing patients and physicians when treating atrial fibrillation and how acquisitions of pulsed-field ablation tool FARAPULSE is changing the game. This episode is sponsored by Freudenberg Medical. To discuss a partnership with Freudenberg Medical for your EP catheter portfolio, please visit https://ep.freudenbergmedical.com/. Chris Newmarker of MassDevice joins Host Tom Salemi in delivering this week’s Newmarker’s Newsmakers - Abbott, Boston Scientific, Intuitive, and Medtronic. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Why Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovation 1:07:41
1:07:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:07:41In this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries. Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk. Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the magazine’s leadership issue including an in-depth interview he did with former Edwards Lifesciences CEO Mike Mussallem. The three then run through this week’s Newmarker’s Newsmakers - Integra, Olympus, Johnson & Johnson, Boston Scientific, Stryker, and Inari. Go to DeviceTalks.com to register for our conferences and digital events. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 J&J's John Murray and Dr. Kerber on neurovascular innovation and lessons in imagination & resilience 1:17:01
1:17:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:17:01In this episode of Neuro Innovation Talks, host John Murray interviews Charles "Chuck" Kerber, MD, Emeritus Professor of Radiology and Neurosurgery at UCSD, a pioneering force in neurovascular medicine, whose innovations—such as flow-directed catheters and cyanoacrylates for therapeutic embolization—transformed the field. Dr. Kerber reflects on his Appalachian roots and military experience, highlighting how these influences shaped his views on responsibility, mentorship, and patient-centered care. His philosophy of innovation, grounded in imagination and resilience, offers a blueprint for tackling complex medical challenges. The discussion explores the iterative process of developing life-saving neurovascular devices, from early failures to groundbreaking successes, and emphasizes the vital role of collaboration with industry partners. Dr. Kerber shares stories of his mentorship style, which encouraged creativity and accountability, and its profound impact on the next generation of neurovascular physicians. He also underscores the importance of ethical considerations and humanity in patient care. Looking ahead, Dr. Kerber advocates for the continued integration of creativity and teamwork in addressing future neurovascular challenges. He closes by offering young physicians advice on embracing imagination and perseverance to drive innovation and improve patient outcomes. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Eytan Raz, MD, Boris Pabon, MD, Joseph Horton, MD, John Barr, MD, and special thanks to William Bank, MD. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!…
1 Flow Medical CEO Fried sees huge opportunity to clear pulmonary embolisms; State of DeviceTalks 1:06:19
1:06:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:19In this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round. The story checks all the boxes of a great MedTech story. Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials. Before the interview, Salemi and DeviceTalks Managing Editor Kayleen Brown share news on the expanding DeviceTalks universe including new podcasts, new virtual discussions and a proven way for MedTech companies to tell their stories. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 CEO Mick Farrell on how ResMed keeps on the leading edge of innovation; Our 2024’s Top Newsmakers 1:18:36
1:18:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:18:36In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company’s strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company’s connectivity capabilities, response to wearable technology, and its take on a rival’s recall. This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more. We’ll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.…
1 Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes 56:39
56:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:39In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions. Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care. The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/ Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 How Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mind 1:13:26
1:13:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:26In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology. Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/ MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Todd Brinton shares lessons on mentorship, Edwards’ culture and advancing heart failure innovation 40:46
40:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
40:46In this episode of Structural Heart Talks, Todd Brinton, MD, Chief Scientific Officer & CVP, Advanced Technology at Edwards Lifesciences, discusses Edwards’ vision of future innovative technologies that elevate patient care and expand the possibilities of structural heart therapies. Brinton reflects on his journey from biomedical engineering to pioneering roles in MedTech, including his work at Shockwave Medical, and shares how these experiences shaped his mission to create impactful technologies for patients worldwide. The conversation dives deep into Edwards’ evolving focus on structural heart failure and non-valvular structural heart therapies, emphasizing investigational programs that challenge traditional approaches and push the boundaries of interventional cardiology. Brinton highlights how Edwards fosters a mission-driven culture of collaboration, uniting engineering, clinical expertise, and market insights to tackle some of the most complex challenges in cardiac care. The episode also underscores the transformative role of mentorship in Brinton’s career and his commitment to paying it forward by empowering others in the MedTech space. Drawing on personal stories, Brinton illustrates how embracing failure and leveraging diverse perspectives have driven innovation at Edwards, paving the way for new therapies that can improve care for patients globally. * Please note that this episode was recorded before the sale of Edwards’ Critical Care business unit to BD, which closed on Sept 3, 2024. Thank you to Integer for sponsoring this episode of Structural Heart Talks. To learn more about how Integer supports medical device companies, visit www.Integer.net. Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.…
1 BD’s Tesh Elavia unpacks his own career, suggests new engineers don’t shy away from challenges 56:17
56:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:17In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi unpacks the career of Tesh Elavia, vice president of research and development at BD’s surgery division. Elavia’s parents strongly encouraged him to leave his home in India to study in the states. Listeners will hear how he built that uncertain start into a stellar MedTech career. This episode is sponsored by FPT. Learn more about the company in the podcast or visit FPTsoftware.com MassDevice Editor Chris Newmarker kicks this off with the Newmarker’s Newsmakers - Edwards Lifesciences, GE Healthcare, Movano Health, Boston Scientific and layoffs in the MedTech Industry. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 J&J MedTech’s John Murray and Dr. Jacques Moret on early neurovascular innovation & mentorship 1:05:03
1:05:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:03In this episode of Neuro Innovation Talks, Host John Murray interviews Professor Jacques Moret, MD, Professor and Consultant Interventional Neuroradiology and Honorary Chairman, NEURI center, Bicetre University Hospital, a pioneer in neurovascular intervention, as he reflects on the early challenges and groundbreaking innovations that shaped the field. Dr. Moret recounts the origins of balloon remodeling for brain aneurysm treatment, detailing the iterative process of developing this transformative technique and the critical role of collaboration with industry leaders. He highlights the technological and ethical considerations that informed his work, emphasizing the balance between innovation and patient safety. The conversation delves into his philosophy of mentorship, the significance of anatomical knowledge in neurointervention, and the importance of maintaining humanity in patient care. Dr. Moret also discusses the future of neurovascular treatment, advocating for MRI-compatible devices and real-time functional imaging to enhance procedural outcomes. Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: www.confluentmedical.com. Special thanks to the following, the Neuro Innovation Talks podcast series would not be possible without their support: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Christophe Cognard, Dr. Laurent Spelle, and Dr. Vitor Pereira Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!…
1 Where Intuitive's Iman Jeddi sees da Vinci 5 - and robotics - fitting into the future of surgery 45:41
45:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
45:41Where does Iman Jeddi see Intuitive’s da Vinci 5 - and robotics - fit into the future of surgery? In this episode of IntuitiveTalks, Iman Jeddi, PhD, senior vice president and general manager of the company’s multi port platform, shares a vision for the future of surgery where robotic systems elevate the performance of surgeons and deliver greater care equity. Jeddi’s career started in biomedical engineering, taking her through several start-ups and ultimately, Abbott. Her lifelong career goal to create technology that improved care for the many led her to join Intuitive Surgical in 2013. Jeddi has held multiple leadership roles in engineering, operations, and quality. Prior to taking her current post, Jeddi was general manager of the single-port platform, da Vinci SP, so she brings a uniquely comprehensive perspective to the company’s surgical robotic portfolio. The interview begins and ends with a personal story illustrating her belief in building medical devices and tools that can deliver better care for as many patients as possible. Thank you to Aptyx for sponsoring this episode of IntuitiveTalks! Please visit www.aptyx.com to learn more about how Aptyx can help you manufacture your competitive edge. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.…
1 How a love of science led SandboxAQ’s Kit Yee Au-Yeung to find better ways to monitor the heart 56:26
56:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:26In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Kit Yee Au-Yeung, general manager of AQMed at SandBoxAQ, an Alphabet spinout using AI and sensors to develop new tools in several industries. Sandbox’s medical group is using these new technologies to develop advanced AI-powered magnetocardiography (MCG) technology to improve cardiac diagnostics. MassDevice’s Chris Newmarker also returns with his Newmarker’s Newsmakers including - Dr. Mehmet Oz, CMS, Supira, GE Healthcare and Medtronic. This episode is sponsored by DeviceTalks Boston. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Edwards' Larry Wood discusses TAVR evolution, new clinical paradigms, and addressing treatment gaps 37:15
37:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
37:15In this episode of Structural Heart Talks, Larry Wood, Corporate VP and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart at Edwards Lifesciences, discusses the transformative journey of transcatheter aortic valve replacement (TAVR) and the SAPIEN valve. Wood reflects on the innovation that enables minimally invasive heart valve replacement, which has become the standard of care for severe aortic stenosis and offers patients faster recovery and greater independence. The conversation explores Edwards’ efforts to expand access to TAVR, emphasizing the importance of reducing undertreatment and addressing outdated clinical guidelines that delay intervention. Wood also highlights findings from the recent EARLY TAVR study, which challenges long-standing paradigms and advocates for changes to the guidelines to allow earlier treatment of aortic stenosis before symptoms appear. Tune in to the 2021 episode of DeviceTalks Weekly where Host, Tom Salemi visits with Larry Wood to discuss the "Complete History of the SAPIEN TAVR," here: https://www.devicetalks.com/the-complete-history-of-the-sapien-tavr-from-pvts-emerging-idea-to-edwards-lifesciences-success/ Thank you to Confluent Medical Technologies for sponsoring this episode of Structural Heart Talks. To learn more about how Confluent Medical supports medical device companies, visit: www.confluentmedical.com. Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.…
1 Can T45 Labs use its cross-country connections to bypass MedTech’s early-stage funding shortage? 55:32
55:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:32In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Marwan Berrada, founder and managing partner of Santa Clara-based T45 Labs about how incubators can start new companies at a time when early-stage funding is scarce. MassDevice Editor Chris Newmarker deliveres his Newmarker’s Newsmakers including GE HealthCare, Zimmer Biomet, Momentis Surgical, Johnson & Johnson MedTech and, of course, the news surrounding HHS. This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Andy Pierce shares how Stryker is “fighting on its front foot” through R&D and aggressive M&A 57:08
57:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
57:08In this StrykerTalks episode, Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, shares his insights on the company’s commitment to innovation, growth, and patient-centered care. Pierce reflects on his 29-year journey with Stryker, highlighting the high-performance culture shaped by entrepreneurial spirit, growth targets, and strategic acquisitions. He discusses how Stryker’s decentralized structure supports quick, localized decision-making while fostering collaboration across its business units. The conversation also explores the company's M&A strategy, focusing on acquisitions that bring de-risked, high-impact technologies that align with Stryker’s long-term goals. Pierce provides an inside look at Stryker's engagement with the soft tissue robotics space, its approach to balancing internal and external innovation, and the proactive steps Stryker takes to address healthcare staffing shortages with technology. Thank you to Vantedge Medical for sponsoring this episode. To learn more about how Vantedge Medical works with medical device companies, visit www.vantedgemedical.com Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 How frustration on the battlefield and ER led Andrew Napier to build a better intubation device 1:06:10
1:06:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:10In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi interviews Dr. Andrew Napier, a former army medic and ER doc who saw a need for sh*t that works, specifically an intubation tool that allowed for easier access to the airway. He developed his own device and started a company, IntuBlade, to make his vision a reality. Thank you to Dr. Napier and all listeners who have served in the military. Happy Veterans Day. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Philips, Precision Neuroscience, Integra Lifesciences, Boston Scientific, and Johnson & Johnson. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.…
1 J&J MedTech Neuro’s Murray & Vinuela on pioneering the neurovascular field, inspiration & mentorship 1:06:33
1:06:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:33In this episode of Neuro Innovation Talks, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, John Murray, returns to the DeviceTalks podcast studio to spotlight one of the foremost pioneers in neurointervention, Fernando Vinuela, MD, Professor Emeritus of UCLA Interventional Neuroradiology. Dr. Vinuela shares his journey through the groundbreaking evolution of neurovascular treatments and the collaborative spirit that propelled early advancements in stroke care. From his foundational work on detachable coils to his transformative mentorship, Dr. Vinuela reflects on his contributions to neurointervention and the significant milestones that have shaped the field. He also provides insights into his impactful work in Brazil, where he has helped establish stroke treatment programs, expanding the reach of life-saving neurovascular care. Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: https://confluentmedical.com. Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Vinuela, Dr. Satoshi Tateshima, Dr. Dileep Yavagal. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!…
1 Phagenesis CEO Hoskins on helping stroke survivors recover; How Distalmotion will target ASCs 1:15:39
1:15:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:15:39In this episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker tackle some of the weeks’ biggest news including the FDA giving a nod to Distalmotion’s Dexter robot and the Yankees blowing the World Series. Distalmotion CEO Greg Roche visits to share his thoughts on both. Then Tom interviews Chad Hoskins, CEO of Phagenesis, a startup developing a neurostimulation device that could help stroke survivors recover. This week’s Newmaker’s Newsmakers include Medtronic, Masimo, Exactech, Solventum and you already know about this week’s number one. This episode is sponsored by DeviceTalks Boston. Register now at Boston.DeviceTalks.com. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Intuitive’s Barten on Europe’s surgical robotics adoption, healthcare shifts & regulatory demands 36:08
36:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
36:08In this episode of IntuitiveTalks, Dirk Barten, Senior VP and GM of EU Commercial and Marketing at Intuitive, takes us through Europe's unique surgical robotics landscape. He discusses the differences in adoption rates between the US and Europe, where surgical robotics uptake has lagged by about five to seven years. Barten also explains the critical role Intuitive’s digital ecosystem plays in supporting surgeons and healthcare teams throughout Europe. Through tools like tele-education and digital hubs, Intuitive is providing accessible training and data support, which he believes are essential in driving improved patient outcomes and meeting hospitals' needs for more integrated and efficient surgical solutions. In addition, Barten explores how healthcare system consolidation in major European countries is reshaping hospital networks, leading to increased centralization of complex procedures. He highlights Intuitive’s investment in expanding its infrastructure across Europe, with new sites in Switzerland, Germany, and the UK, underscoring Intuitive’s confidence in the region’s growth potential despite ongoing economic pressures. Thank you to Kollmorgen for sponsoring this episode. To learn more about how Kollmorgen works with medical device companies, please visit: www.kollmorgen.com. And that’s not all! Explore some of Kollmorgen’s success stories below: 1. Kollmorgen and Stereotaxis Advance the Precision and Safety of Surgical Robots | https://www.kollmorgen.com/en-us/case-studies/kollmorgen-and-stereotaxis-advance-precision-and-safety-surgical-robots 2. Enabling New Surgical Possibilities with High-Torque, Low-Temperature and Compact-Size Motors | https://www.kollmorgen.com/en-us/case-studies/enabling-new-surgical-possibilities-high-torque-low-temperature-and-compact-size Thank you for listening to the IntuitiveTalks Podcast. Subscribe to the DeviceTalks Podcast Network on every major podcast platform.…
1 Medtronic’s Chief AI Officer Katra talks AccuRhythm AI, surgical robotics & ethical AI innovations 1:06:08
1:06:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:08In this episode of DeviceTalks AI, Host Kayleen Brown sits down with Medtronic’s VP & Global Chief AI Officer, Rodolphe Katra, PhD, MBA, discusses the pivotal role of AI in advancing MedTech and how Medtronic is responding. Dr. Katra walks us through Medtronic’s AccuRhythm AI, which enhances cardiac monitoring by improving arrhythmia detection and reducing false positives through cloud-based algorithms. He also explores how AI is being integrated into Medtronic’s surgical robotics platforms to boost precision and enable personalized care. Additionally, Dr. Katra highlights Medtronic’s AI Compass, a set of ethical guidelines ensuring AI is used securely, without bias, and in a way that improves patient outcomes. Lastly, Katra offers key insights into how Medtronic is using AI to innovate both cardiac care and surgical robotics while maintaining a strong commitment to ethical AI practices. This conversation comes to you courtesy of our episode sponsor, AcuityMD. To learn more about AcuityMD, visit www.acuitymd.com. Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!…
1 Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity 33:32
33:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
33:32In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation. Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions. Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations. Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 Hear the final word about DeviceTalks West: Live recording of DeviceTalks Weekly on-stage 37:16
37:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
37:16In this episode of the DeviceTalks Weekly Podcast, the DeviceTalks team wraps up the two amazing days of insights and networking at DeviceTalks West. Tom Salemi, Kayleen Brown and Chris Newmarker welcome guests Alexis Moores, Senior Account Manager, and Steven Thill, Senior Director of Infor, which announced a partnership with NVIDIA at DeviceTalks West, the culmination of a connection forged at DeviceTalks Boston! Thank you to Infor for sponsoring this episode of DeviceTalks Weekly. To learn how Infor supports MedTech companies visit www.infor.com. The panel covers a few of the highlights from the event discussion surgical robotics, AI, interventional tools, women’s health. But first, we unpack the details of PUMPKINGATE! Thanks for listening to this episode of the DeviceTalks Weekly Podcast.…
1 Hear closing arguments for attending DeviceTalks West and a preview of MedTech Innovator’s Finals 52:51
52:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
52:51In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi opens by making a strong case for MedTech people to attend DeviceTalks West, which is happening on Oct. 16-17. Go to West.DeviceTalks.com to register. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers – Women’s Health, Philiips, Nyxoah, CMR Surgical, and Johnson & Johnson MedTech. Finally, Paul Grand, CEO of MedTech Innovator, introduces DeviceTalks listeners to the five finalists who will compete for the 2024 Early-Stage Grand Prize. The winner will be voted for at the AdvaMed annual meeting in Toronto. Thank you for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Can Andromeda create an autonomous surgical robot? CEO Damiano makes case here and DeviceTalks West 1:02:58
1:02:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:58In this week’s episode of the DeviceTalks Weekly Podcast, Nick Damiano, co-founder and CEO of Andromeda Surgical, previews his talk at DeviceTalks West by introducing listeners to the potential of autonomous surgery. Still early goings on, but Damiano paints and interesting picture of the future. If you want to see the future register at West.DeviceTalks.com. Speaking of the future, Host Tom Salemi speaks with Brody Galloway, a young MedTech professional who has turned his life’s healthcare experiences into a love of the industry and a drive to help. Anyone who wants to help should go to EnvisionMedtech.org. MassDevice Editor Chris Newmarker returns with his Newmarker’s Newsmakers – Surgical Robotics, Medtronic, ResMed, Layoffs and, of course, Baxter Healthcare. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode of this or other industry-leading podcasts.…
1 J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments 56:54
56:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:54In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry. In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes. Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com. Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!…
1 Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West 45:54
45:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
45:54Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements. If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%. MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week - Route 92, Stryker Medtronic, Siemens Healthineers, Masimo and urology companies. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network.…
1 Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact 22:23
22:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:23In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership. Markowitz highlights the importance of the surgical structural heart business, with a strong emphasis on innovation and collaboration with cardiac surgeons. He emphasizes Edwards' 65-year legacy in innovation driven by partnerships with the surgical community, focusing on addressing unmet patient needs. The conversation also touched on the RESILIA portfolio, featuring surgical valves and conduits, and highlights ongoing clinical trials. Looking ahead, Markowitz shares his optimism about the future of the surgical structural heart business, emphasizing the need to bring more patients into the treatment system and the potential for growth in emerging markets. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.…
1 DeviceTalks West Keynote Endiatx CEO Torrey Smith on why he launched one of MedTech’s Moonshots 1:13:34
1:13:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:34In this episode of the DeviceTalks Weekly, Host Tom Salemi interviews Endiatx CEO Torrey Smith, who will be the closing keynote speaker at the DeviceTalks West conference on Oct. 16-17 at the Santa Clara Convention Center. Smith talks about his journey into MedTech. Why he quit his job. And where his dream of building a swallowable surgical robot can lead him and his company. Register at West.DeviceTalks.com to see a demonstration of PillBot! Use the code DTPod25 to save 25%. In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker highlights the top MedTech stories of the week from Boston Scientific, Medtronic, Synchron, Shockwave (now part of Johnson & Johnson Medtech) and Masimo. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Abbott’s Jones-McMeans and Dr DeRubertis on PAD below-the-knee, LIFE-BTK trial & Esprit BTK approval 47:42
47:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
47:42In this episode of AbbottTalks, Jennifer Jones-McMeans, PhD, Divisional VP of Global Clinical Affairs at Abbott and Brian DeRubertis, MD, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center tackle the complexities of treating peripheral arterial disease (PAD) below the knee, particularly chronic limb-threatening ischemia (CLTI), a severe form of PAD that drastically impacts patients' quality of life and longevity. In the episode, the two discuss Abbott's Esprit BTK System, the first-and-only FDA-approved drug-eluting resorbable scaffold for infrapopliteal CLTI. Dr. Jones-McMeans explains how Esprit BTK works by releasing a drug that prevents artery re-narrowing, crucial for maintaining sustained blood flow and promoting wound healing. Later, they walk us through the pivotal LIFE-BTK trial, a significant milestone that demonstrated Esprit's efficacy and led to its FDA approval. They also highlight the importance of including diverse patient populations in clinical trials, particularly those disproportionately affected by PAD, such as African Americans, Latinos, Native Americans, and women. This inclusive approach not only ensures the treatment's effectiveness across varied demographics but also sets a precedent for future trials. Thank you to Freudenberg Medical for sponsoring this episode of AbbottTalks. For more information on how Freudenberg Medical works with medical device companies, visit www.freudenbergmedical.com. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 Hear Kandu’s mission to empower stroke survivors, Medtronic’s Goodheart on lifting women in MedTech 1:01:20
1:01:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:01:20In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi chats with Managing Editor Kayleen Brown about the upcoming DeviceTalks West meeting. This week’s episode features an interview Brown did with Medtronic’s Nina Goodheart at the Women in Medtech Breakfast at DeviceTalks Boston. The conversation previews the Women in Medtech Luncheon interview featuring Cecilia Soriano, president, infusion therapies and technologies, at Baxter International. In our second interview, Salemi interviews Kirsten Carroll, CEO of Kandu Health about that company’s work to empower stroke survivors. Carroll will be speaking at DeviceTalks West. Register at West.DeviceTalks.com to register. Use the code DTPOD25 to save 25%. Subscribe now to the DeviceTalks Podcast Network.…
1 Boston Scientific’s Baker on how Intracept battles back pain. Hear full story at DeviceTalks West 1:00:45
1:00:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:45In this episode of DeviceTalks Weekly podcast, Host Tom Salemi introduces one DeviceTalks West speaker. Ray Baker, MD, vice president and chief medical officer, neuromodulation at Boston Scientific, introduces DeviceTalks Weekly listeners to Intracept, a procedure approved by the FDA to treat forms of back pain. Dr. Baker will be a speaker at DeviceTalks West on Oct. 17 where the clinical and commercial details will be discussed. Register now at West.Devicetalks.com. Use the code mentioned in the podcast to save 25% off the price of registration. Salemi also invites listeners to attend the Connected Health Series taking place Sept. 10-12. Sponsored by Maxon and S3 Connected Health, virtual attendees can hear from Adona Medical, Baxter, BD and Canary Medical about the future of sensors and other connected technologies. MassDevice Editor Chris Newmarker brings another batch of Newmarker’s Newsmakers including Novocure, Medtronic, Johnson & Johnson MedTech, Edwards Lifesciences and the Big 100. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Hear HighRidge Medical’s plans to scale the spine market; a preview of the MedtechVISION conference 1:05:38
1:05:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:38In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC. Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 GE HealthCare’s Samset on how deal led to building Caption AI for Vscan and securing FDA approval 58:03
58:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
58:03In this episode of DeviceTalks AI, host Kayleen Brown sits down with Eigil Samset, PhD, General Manager for Cardiology Care at GE HealthCare. Dr. Samset takes us through his vast experience stretching over nearly three decades and discusses the transformative role of AI in advancing healthcare, particularly how GE HealthCare is leveraging AI to streamline and enhance cardiology care pathways. In the episode, Dr. Samset gives us the backstory of the 2023 Caption Health acquisition and provides insights into the inspiration behind Caption AI for use in Vscan, which democratizes cardiac assessments by making them accessible to less experienced users. The conversation touches on the regulatory challenges, the importance of multi-disciplinary collaboration, and GE HealthCare's strategic approach to integrating AI – aiming to improve patient outcomes and care pathways significantly. This conversation comes to you courtesy of our episode sponsor, DeviceTalks West. Listen to the episode for 25% OFF the registration rate: West.DeviceTalks.com. Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!…
1 How Dohadwala uses analytics, her gut, and the benefits of diversity to build a strong VC portfolio 1:11:57
1:11:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:11:57In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Tasneem Dohadwala, founding partner at Excelestar Ventures about how the small firm employs analytics, know-how, and a belief that companies are best led by diverse management teams. MassDevice Editor Chris Newmarker returns with his Newmarker's Newsmakers including outgoing FDA CDRH Leader Jeff Shuren, the New York Times, Medtronic, Zoll Medical, Vyaire Medical, Johnson & Johnson MedTech, V-Wave, and Edwards Lifesciences. This episode is sponsored by DeviceTalks West. Listen to the podcast to hear the discount code that will save you 25% of the price of registration. Go to West.DeviceTalks.com. We’ll also hear a message from regulatory firm MedTech Impact Partners. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.…
1 ZB’s Lancaster talks next-gen knee systems, robotics and building a new MedTech regional powerhouse 41:08
41:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
41:08In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet. Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries. Please join us September 10-12th for DeviceTalks's LIVE Connected Health webinar series. Register at no cost: https://event.on24.com/wcc/r/4613481/E930EFFA706588C378BEAA97824C7CE2/5516160 Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to the Ortho Innovation Talks podcast, featuring Zimmer Biomet!…
1 Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts 36:58
36:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
36:58In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to their complex and varied nature. He details Edwards Lifesciences' efforts to innovate in this space with technologies like the PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first transcatheter tricuspid valve replacement approved in both the US and Europe. Later, Chopra explains the importance of a focused approach at Edwards Lifesciences, where the company’s specialization in structural heart disease enables deeper knowledge and more targeted innovation. The conversation also explores the intricate process of planning and executing these advanced procedures, which require close collaboration between interventional cardiologists and echocardiographers. Chopra underscores the ongoing commitment to clinical evidence and real-world outcomes as key drivers of future success in this rapidly evolving field. Looking ahead, he emphasizes the need to increase awareness, diagnosis, and treatment rates for valve diseases, noting that many patients still go untreated due to a lack of awareness. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.…
1 May Health VC and CEO give glimpse into promising startup, assessment of women’s health investments 1:04:39
1:04:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:04:39In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi delves into the opportunities in women’s health devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. Sofinnova invested in May Health, which is developing a device-based therapy for Polycystic ovary syndrome, a common cause of infertility. Is the financing environment for Women’s Health companies improving? What will drive investors to commit more capital. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers back featuring news from NeuroOne, Pentax, Allurion, Medtronic and Abbott. Associate Editor Sean Whooley joins the NewNew team to break down the new partnership between Abbott and Medtronic in the diabetes business. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.…
1 Intuitive CMO Myriam Curet unpacks DaVinci 5 launch, growing robotics adoption, and clinical impact 40:45
40:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
40:45In this episode of IntuitiveTalks, we welcome back Myriam Curet, MD, EVP & Chief Medical Officer at Intuitive, to discuss the transformative impact of surgical robotics on patient care, focusing on the evolution of the DaVinci system, including the recent DaVinci 5 launch. In the episode, Dr. Curet explains how surgical robotics like DaVinci have shifted from being seen as advanced technology to becoming an integral part of surgical practice, enhancing patient outcomes and surgeon efficiency. She also stresses the significance of real-world data and meta-analyses in validating surgical robotic systems and providing a profound understanding of their benefits across various categories of surgery. Lastly, Dr. Curet offers a behind-the-scenes look at the meticulous development and approval process of the DaVinci 5 system. Thank you to Paragon Medical for sponsoring this episode of IntuitiveTalks. Please visit https://www.paragonmedical.com/ to learn more about how Paragon Medical supports medical device companies. Thank you for listening to the IntuitiveTalks podcast. Please subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 How can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knows 1:16:47
1:16:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:16:47In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.…
1 New CEO Landon on the power of mentorship and the strategy behind expanding Natus Neuro DX platform 56:36
56:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:36In this episode of the DeviceTalks Weekly, Chris Landon returns to the podcast but this time as CEO of Natus Neuro, a company building out a monitoring, diagnostics and data collection platform to help diagnose and treat neurological disorders. This episode is sponsored by DeviceTalks West. Host Tom Salemi and Chris Newmarker, editor of MassDevice, review this week’s Newmaker’s Newsmakers - aka the week’s biggest medtech stories. Top newsmakers include Imperative Care, the FDA, neuro start-Ups, Inspire Medical and Edwards Lifesciences. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.…
1 Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval 41:40
41:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
41:40In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience helping to develop the revolutionary dual-chamber leadless pacemaker system, taking us through the significant challenges and triumphs of creating a device that ensures precise coordination between the heart’s atrial and ventricular chambers without traditional leads. Fishler recounts the meticulous development process, from initial concept testing using rudimentary "submarines" in saline tanks to achieving FDA approval. He highlights the deliberate approach taken to ensure safety and effectiveness, resulting in a device that now benefits patients with more comprehensive cardiac support. Lastly, he explains the innovative i2i communication technology, which uses electrical impulses to enable seamless device interaction, a concept likened to a “moonshot” due to its unprecedented nature. Thank you to ProMed for sponsoring this episode of AbbottTalks. To learn more about ProMed’s prototype services, visit: https://promedmolding.com/capabilities/prototyping/ Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval 1:00:43
1:00:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:43In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients. But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe now to the DeviceTalks Podcast Network.…
1 Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system 33:13
33:13
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
33:13In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition and how Vocera's dynamic clinical workflow addresses staffing shortages and enhances efficiency. Additionally, the episode covers Stryker's new LIFEPAK 35 monitor/defibrillator, advancements in the 1788 visualization platform, and ongoing innovations in the neurovascular space. Pierce also touches on plans for incorporating Vocera into more Stryker products and the company's interest in soft-tissue surgical robotics. Want more from Andy Pierce? Explore his previous appearances on the DeviceTalks Podcast Network. Prior appearance on StrykerTalks: https://www.devicetalks.com/pierce-talks-innovation-vocera-ascs-and-why-nurses-hug-strykers-neptune-waste-management-system/ Prior appearance on DT Weekly: https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/ Thank you to S2 Insight, Inc. for sponsoring this episode. To learn more about how S2 Insight, Inc. supports medical device companies, visit https://www.s2insight.com/case-studies. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy 54:23
54:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
54:23In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients. This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Hologic's FDA-cleared Genius Digital Dx Systems leads AI innovation in cervical cancer prevention 57:38
57:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
57:38In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics. In our keynote interview, we speak with Michael Quick, Vice President of R&D and Innovation in Cytology & Oncology at Hologic. Quick shares his journey from a pre-med student to a leader in cytology innovation. He discusses the development and impact of Hologic’s Genius Digital Diagnostic Systems, the first FDA-approved digital cytology system, which leverages AI to enhance cervical cancer screening accuracy and efficiency. Michael emphasizes Hologic’s dedication to women's health and the critical role of AI in addressing the shortage of skilled cytologists, ensuring faster and more accurate diagnostics for patients worldwide. He also touches on the challenges and opportunities faced during the FDA approval process and the importance of early and collaborative engagement with regulatory bodies. We also hear from Dr. Wael Yared, Chief Technology Officer at Tecan, who highlights Tecan's contributions to cancer research and diagnostics. Dr. Yared elaborates on the company's innovations in liquid biopsy and solid tissue biopsy workflows, which leverage AI to streamline processes and reduce errors. He emphasizes the significance of partnerships in driving medical advancements and the role of AI in personalized medicine and multiomic capabilities. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about Tecan visit, https://partnering.tecan.com Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!…
1 Mullings and Bell unpack SRS 2024: Surprises, disappointments and where is surgical robotics headed? 1:13:00
1:13:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:00In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry experts Steve Bell and Joe Mullings of The Mullings Group. The discussion ranges beyond the meeting into the state of Surgical Robotics. This episode is sponsored by DeviceTalks West. Go to West.DeviceTalks.com for more information. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Boston Scientific Interventional CMO talks CAD, stents, drug-coated balloons and the lure of history 1:09:05
1:09:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:05In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon. This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com. MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting. Salemi also shares some thoughts from the Annual Meeting of the Society of Robotic Surgery. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.…
1 CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device 48:10
48:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
48:10In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Asensus Surgical on reshaping robotic surgery with augmented intelligence; AWS's purpose-built AI 1:17:35
1:17:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:17:35In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between augmented intelligence and artificial intelligence and how Asensus is leveraging these technologies to improve surgical outcomes. Anthony discusses the inception and evolution of Asensus Surgical's innovative robotic platforms, including the Senhance and Luna systems, and delves into the core advantages of using augmented over artificial intelligence to aid surgeons. He describes the Intelligent Surgical Unit (ISU), its unique regulatory pathway, and its pivotal role in providing the surgeon with real-time context, ensuring higher precision, consistency, and reduced cognitive fatigue during surgeries. To get the full story on the Karl Storz acquisition of Asensus Surgical, visit: https://www.massdevice.com/asensus-to-be-acquired-karl-storz/ In the second part of the episode, GM of Health AI at Amazon Web Services (AWS), Tehsin Syed, talks about the intersection of healthcare, life sciences, and AI and how AWS is helping healthcare and life sciences organizations leverage AI without the need for extensive technical expertise. Tehsin highlights AWS services like Comprehend Medical and HealthScribe, which are designed to simplify the processing and analysis of healthcare data. He also discusses the potential of generative AI in accelerating drug discovery, clinical trial optimization, and personalized medicine. Make sure to check out DeviceTalks Spotlight, a growing library of insights and expertise from the best in the medical device business: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4598161/devicetalks-spotlight Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!…
1 OIV’s Hunter-Syed on corporate venture capital’s growing influence; Bell previews SRS annual meeting 47:35
47:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
47:35In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interviews, Host Tom Salemi speaks with Abby Hunter-Syed, director of Olympus Innovation Ventures (OIV), the corporate arm of Olympus, the medical giant. Hunter-Syed explains how her own entrepreneurial experience led her to discover the joy of supporting start-ups. In this interview she explains why she favors open communication and how entrepreneurs can best approach OIV for capital. Before that conversation, we visit with Surgical Robotics Expert Steve Bell, an MedTech veteran who now advised start-ups. We preview the upcoming annual meeting of the Society of Surgical Robotics, which promises to unveil many interesting new surgical robotics systems. You can find out more about Steve Bell at www.howtostartupinmedtech.com. This episode is sponsored by DeviceTalks West. Registration opens next week. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Imaging pioneer Arun Menawat explains how MR-driven Profound Medical will upend traditional surgery 1:10:33
1:10:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:10:33In this episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi visits with Arun Menawat, CEO and Chairman of Profound Medical, developer of incision-free therapies which combine real-time MR imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. In the conversation we’ll discuss Menawat’s past successes and his vision for the future of surgery. Go to profoundmedical.com for more information. Thank you to Profound Medical for sponsoring this episode of the DeviceTalks Weekly podcast. We’re also thrilled to announce the return of the Newmarker’s Newsmakers! Chris Newmarker returns with a wrap up of the hottest news on MassDevice.com, the medical device industry’s leading news source. This week we’ll cover news from Microbot Medical, Stryker, BD, Edwards and others. If you want to hear Joe Mullings take on the Karl Storz/Asensus deal go here. https://www.devicetalks.com/can-sovato-health-build-digital-highway-for-remote-robotic-surgery-unpacking-the-storz-asensus-news/ Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.…
1 How Enovis is prepping for foot & ankle street fight; A chat about Medtronic’s Percept RC DBS System 1:20:06
1:20:06
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:20:06In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Gary Justak, president and general manager of Enovis’ foot & ankle business, about the rising war in the orthopedic extremities space. Co-hosts Tom Salemi and Chris Newmarker also host Jason Feipel, senior product development director of Medtronic’s Brain Modulation business, to find out details about the Percept RC DBS System. Andie Pequegnat, Director of Strategic Projects at Resonetics, teaches us more about nitinol. Resonetics sponsored this episode of the DeviceTalks Weekly Podcast and will host a DeviceTalks Tuesday discussion about nitinol later in June. Go to Resonetics.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Don’t miss a episode by subscribing to the DeviceTalks Podcast Network.…
1 Transforming surgery with Versius: bringing robotic assisted surgery to patients worldwide 58:32
58:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
58:32In this episode of the DeviceTalks Weekly Podcast, we’ll replay our Day 2 opening keynote at DeviceTalks Boston with three senior leaders from CMR Surgical, creator of the versatile Versius surgical robotic systems. Co-Founder Mark Slack, MD, now CMO, and Luke Hares, now CTO, identified several problems facing the healthcare system and explained why they saw surgical robotics as the solution. Longtime Medical Device Leader Supratim Bose, now CEO of the company, lends his insights in how Versius can fill a huge need for healthcare systems and hospitals. This episode is sponsored by Qt Group. Listen to understand how they can help your medical device development or go to Qt.io for more information. Thank you for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network to listen to future episodes of this and our family of medical device podcasts. DeviceTalks.com…
1 Medtronic Endoscopy's Chief AI Officer on Transforming Dx through AI and Patient-Centric Design 58:59
58:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
58:59In this episode of DeviceTalks AI, we are joined by Ha Hong, PhD, Chief Artificial Intelligence Officer of Medtronic Endoscopy about integrating AI into Medtronic's endoscopy unit, the impact on healthcare outcomes, patient-centric design, and the future of AI in the medical device industry. Watch or listen to the episode to: - Discover how Ha's research coincided with the rise of deep learning, a pivotal technology in modern AI, and how it shaped his work in emulating visual perception processing in the brain. - Better understand Ha's instrumental role in developing the first FDA-approved AI-powered cardiac ultrasound guidance system, a groundbreaking innovation in cardiology. - Learn about Ha’s move to Medtronic and his vision for integrating AI into endoscopy, highlighting the potential for AI to revolutionize gastrointestinal diagnostics and treatment. - Gain insights into Ha's philosophy of patient-centric AI design, emphasizing the importance of prioritizing patient needs and safety in AI development for healthcare. In the episode, we also sit down with Joe Mish, VP of Sales at SmartTRAK to better understand how SmartTRAK is using AI to enhance their market intelligence solutions, combining the traditional robust analysis with advanced algorithms for more nuanced, speedier insights in the medtech industry. This conversation comes to you courtesy of our episode sponsor, SmartTRAK. To learn more about SmartTRAK, visit www.smarttrak.com. Please subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!…
1 BD’s CTO Beth McCombs Explains How Medtech Innovation Can Deliver Real Help to Patients, Providers 50:27
50:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
50:27In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD. This is a replay of the opening keynote interview at DeviceTalks Boston. This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.…
1 Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage 42:45
42:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
42:45In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business. Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com. Please subscribe to the DeviceTalks Podcast Network.…
1 Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care 42:52
42:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
42:52In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition. Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations. Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage. Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders 1:03:00
1:03:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:00In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand. We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic. Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.…
1 How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences 44:39
44:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:39In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies. In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders. TL;DR – Key Takeaways: - The integration of market insights from the beginning is crucial for successful medical device commercialization. - Collaborative efforts across various functions are vital to address the comprehensive demands of product development. - Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!…
1 Medtronic’s Seidel Maps out Future for Electrophysiology, Pulsed-Field Ablation Portfolio 1:09:19
1:09:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:19In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector. Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference! Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network…
1 Spencer Stiles on what's driving Stryker’s ortho growth with surgical robotics and strategic M&A 37:24
37:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
37:24In this episode of StrykerTalks, Spencer Stiles, Group President of Orthopaedics and Spine at Stryker, discusses Stryker's latest advancements shaping the future of orthopedics and spine care, including an update on the significant role of Mako, Stryker’s pioneering robotic arm-assisted system. Additionally, Stiles discusses the expansive reach of these innovations, emphasizing their rapid adoption across global markets, particularly in Asia, where Stryker’s advanced solutions meet diverse clinical needs and operational settings. He shares insights into how these technologies cater to the unique challenges faced in different regions, enhancing Stryker's impact on global healthcare landscapes. The conversation further explores Stryker’s strategic growth initiatives, particularly its approach to mergers and acquisitions. Stiles outlines how these moves are carefully crafted to align with Stryker’s long-term vision, ensuring that each acquisition not only expands their market presence but also complements their existing portfolio. Thank you to DornerWorks for sponsoring this episode. To learn more about how DornerWorks supports medical device companies, visit www.DornerWorks.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network on every major podcast platform.…
1 Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market 40:43
40:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
40:43In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.…
1 Can Sovato Health Build Digital Highway for Remote Robotic Surgery? Unpacking the Storz-Asensus News 54:42
54:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
54:42In this week’s DeviceTalks Weekly podcast episode, Host Tom Salemi talks with Joe Mullings of The Mullings Group about the Karl Storz and Asensus Surgical News as well as Johnson & Johnson's big play for Shockwave Medical. Then, we talk with the leaders of Sovato Health - Yulun Wang, PhD, chairman & co-founder, and Cynthia Perazzo, Co-founder and CEO, about the startup’s plans to build a fiberoptic network to enable remote robotic surgery procedures. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to catch future episodes.…
1 Four years!? Wow, time flies when you’re talking Medtech. Thank you for listening, DeviceTalkers! 35:05
35:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:05In this week’s DeviceTalks Weekly, Host Tom Salemi thanks the DeviceTalks community for the kindness and support of our podcasts and conferences. He also looks back at our four years and replays Episode 1 where he and Chris Newmarker make some prescient calls on the impact of the pandemic while also showing just how different the world was. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.…
1 Can BD’s New MiniDraw System Remove the Pain Points of Blood Testing for Patients, Health Systems 56:06
56:06
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:06In this week’s DeviceTalks Weekly Podcast, Bridget C. Bagnato, worldwide president of specimen management at BD, gives us a glimpse of phlebotomy’s future – the BD MiniDraw, a blood testing system that can run a wide array of diagnostic tests on the blood drawn from a fingertip. How might this change how and where blood is drawn in the future. Thank you to Aptyx for sponsoring this episode! Listen to our interview with CEO Gregg Tobin and go to Aptyx.com for more information. We also include a portion of an interview Co-Host Tom Salemi did with Nikolai Begg, senior director of portfolio R&D, Robotic Surgical Technologies, Medtronic, in this week’s DeviceTalks Tuesday Surgical Robotics Week. To listen to the entire interview or our other episodes with Intuitive or Virtual Incision go here. https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415884/devicetalks-tuesdays Also, listen to hear how you can join a unique networking opportunity at Medtronic on April 30 as part of DeviceTalks Boston. We also introduce the new podcast discount code DTWEEKLY25. Use it when you register to attend at DeviceTalks.Boston.com Thanks for listening to the DeviceTalks Weekly Network. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 How does the internal medical device development process work at large medtechs? 23:45
23:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
23:45In the latest episode of MedtechWOMEN Talks, Rebecca Whitney, SVP, Global Spine President, ZimVie dives deep into what it takes to bring innovative medical solutions to market in a large medtech OEM, weighing the benefits of internal product development against strategic external partnerships. The episode shines a light on the diligent process behind medical device product development, taking into consideration global market nuances, regulatory challenges, and the balance between in-house innovations and external collaborations. Whitney underscores the value of rigorous review stages, which sometimes require difficult decisions like ceasing investment in long-term, costly projects. Key Takeaways: - Tough decisions, like halting a project, are necessary for the betterment of patient care and resource allocation. - Product development incorporates feedback from patients, surgeons, and salesforces to ensure that solutions are practical and market-appropriate. - Strategic external partnerships can optimize development by leveraging outside expertise, allowing large medtechs like ZimVie to focus on their core strengths. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!…
1 How Akura Medical wants to advance thrombectomy; What does da Vinci 5 mean for surgical robotics? 1:13:46
1:13:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:46In this episode of DeviceTalks Weekly Co-Hosts Tom Salemi and Chris Newmarker pay a visit to the Wizard, Joe Mullings of The Mullings Group, to get his take on the disruptive force that is Intuitive’s da Vinci 5. What does this mean to the surgical robotics competitors both big and small? Then Tom Salemi talks with Murali Srivathsa, CEO of Akura Medical, about the company’s aggressive moves to disrupt the thrombectomy. Akura is part of the prolific Shifamed accelerator, so we’ll talk about that innovative powerhouse as well as Srivathasa’s own career. To register for the upcoming DeviceTalks Tuesday Surgical Robotics Week or DeviceTalks Boston go to DeviceTalks.com. Thanks for listening to the DeviceTalks Podcast Network. Subscribe now to the DeviceTalks Podcast Network on any major podcast player.…
1 Abbott electrophysiology leaders highlight current portfolio, give glimpse of potential PFA device 44:17
44:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:17In the latest episode of AbbottTalks, Abbott Cardiovascular's leaders, Christopher Piorkowski, MD, DVP and Chief Medical Officer of Electrophysiology, and Dan Kaiser, Divisional VP Product Development, Electrophysiology, delve into the vast landscape of electrophysiology and the comprehensive approach Abbott is taking towards atrial fibrillation (AFib) treatment. The conversation highlights a potentially innovative pulsed field ablation (PFA) technology and Abbott's broader AFib portfolio, showcasing a commitment to revolutionizing cardiac arrhythmia management. While the Volt™ Pulsed Field Ablation System could represent a significant leap forward with its unique capabilities for creating precise and tissue-selective lesions, Piorkowski and Kaiser emphasize the diversity and depth of solutions Abbott is developing. This includes advancements in diagnostic tools, patient monitoring, and a range of therapeutic approaches designed to offer customized and effective treatment pathways for individuals with AFib. By focusing on a holistic view of patient care, they discuss how Abbott aims to improve clinical outcomes through technological innovation and enhance patients' quality of life by making treatments more accessible, reducing procedure times, and addressing the broad spectrum of needs within the electrophysiology community. With ongoing clinical trials and research, Abbott is positioned at the forefront of addressing the unmet needs in AFib management, underlining the company's commitment to continuous innovation and patient-centered care. Thank you to Cretex Medical for sponsoring this episode of AbbottTalks. For more information on how Cretex Medical works with medical device companies, visit www.cretexmedical.com. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.…
1 What the spaceMIRA Mission Means for Surgical Robots; Cyborgs, Drill Pills & Other Cool Harvard Tech 1:22:00
1:22:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:22:00In this episode of the DeviceTalks Weekly podcast, John Murphy, CEO of Virtual Incision, highlights the headline-grabbing surgical robotics start-up. Virtual Incision followed up a trip to the ISS for a nod from the FDA. What’s next? He talks to Editorial Director, Tom Salemi. But first Shriya Srinivasan, Ph.d, assistant professor at Harvard’s School of Engineering and Applied Sciences, drops some SciFi on Salemi and Chris Newmarker – neuro interfaces, tiny drills that deliver drugs, and much more! Srinivasan will bring her insights to DeviceTalks Boston on May 1! Thanks to DornerWorks for sponsoring this episode. Find out more at DornerWorks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 ZB’s Goyal Explains How Passion for Solving Ortho Challenges Put Him at the Helm of ZB’s R&D Engine 36:39
36:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
36:39In this episode of Ortho Innovation Talks, Nitin Goyal, MD, chief science, technology and innovation officer at Zimmer Biomet (ZB) shares his journey from the OR to the medtech industry. Dr. Goyal oversees ZB’s global innovation, medical education, clinical affairs, and reimbursement strategy. He tells host Tom Salemi about his passion for building solutions to address clinical challenges and improve the surgical experience. Goyal’s own innovations landed him leadership positions at managed care powerhouse, UnitedHealthcare, followed by medtech giant, ZB. Goyal describes how his pursuit of “making an outsized impact” on orthopedic care brought him to ZB, where he leads the global innovation, medical education, and clinical affairs functions. In this talk, he’ll discuss how ZB incorporates smart implants that track and report mobility data, to big data analytics that guide clinical decision-making throughout the episode of care. Goyal explains why he believes we’re at an inflection point in orthopedics and how ZB intends to lead the way. Thank you to our season one sponsors, Millstone Medical and AcuityMD, for supporting this podcast. To learn more about our episode sponsor, Millstone Medical, please visit http://millstonemedical.com. Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to the Ortho Innovation Talks podcast!…
1 How MedTech Color’s Pitch Competition Startup Finalists Are Tackling Healthcare’s Biggest Problems 1:39:16
1:39:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:39:16In this episode of the DeviceTalks Weekly podcast, we meet the 13 finalists for the MedTech Color Pitch Competition, both general and pediatric categories. Editorial Director Tom Salemi and Managing Editor Kayleen Brown ask each entrepreneur about the problems they’re trying to solve and the solutions they’ve developed. Tom and Kayleen also interview MedTech Color’s new executive director, Katrina Holland. The pitch competition takes place March 15. For the list of finalists and registration information go to MedTechColor.org Thank you for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network on any major podcast player.…
1 How do I navigate the clinical affairs process effectively? with Christina Hawley, May Health 41:54
41:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
41:54In this episode of MedtechWOMEN Talks, Christina Hawley, Sr. Director, of Clinical Operations at May Health helps to unravel the clinical trial process for medical devices, emphasizing the non-linear path from early feasibility to pivotal trials and post-market studies; and delves into the meticulous process of gaining FDA approval and even the nuanced differences between clinical affairs and regulatory affairs. TL;DR – Key takeaways: - Close collaboration with cross-functional teams, including R&D, regulatory, quality, and marketing, is key to the success of clinical trials. - Clinical trials must consider the specific regulatory requirements of the targeted geographical markets. - There is no standardized approach to any of the different clinical trials, each must Tune in to gain insights into the complex and surprisingly creative world of clinical research in the medical device industry. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!…
1 InnovHeart CEO Wilson shares vision for TMVR start-up; Our chat with AAOS pitch winner CytexOrtho 1:01:50
1:01:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:01:50In this episode of the DeviceTalks Weekly Podcast, Co-hosts Tom Salemi and Chris Newmarker interview Brad Estes, CEO of CytexOrtho, the winner of a pitch contest staged by AAOS. The company is developing implants that could serve as an alternative therapy to total hip replacement. In our main interview, Tom interviews David Wilson, CEO of InnovHeart, a multinational startup that’s developing transcatheter mitral valve replacement systems to treat patients with mitral valve disease. Wilson talks about his journey into medtech, his decision to shift from engineering to sales, and how life as a global president of a medical device business differs from being a start-up CEO. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.…
1 Sanofi races to the AI forefront in Big Pharma; Plus, Medable's big promises for clinical trials 59:32
59:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
59:32This episode of DeviceTalks AI offers a comprehensive look at the ways AI is poised to upend the pharmaceutical industry. It features an in-depth keynote interview with Helen Merianos, Head of Sanofi's R&D Portfolio Strategy, who provides an inside look into Sanofi's commitment to go "all-in" on AI and data science. Merianos discusses the use of Sanofi's proprietary plai app – an AI-enabled smartphone app that draws from over a billion data points – and its role in establishing a data-driven culture across the company. Additionally, the episode features Michelle Longmire, MD, Co-Founder and CEO of Medable, who discusses the use of generative AI in automating and accelerating clinical trial technology deployment timelines. These applications could cut some timelines in half. Longmire envisions AI's potential to drastically accelerate a development process. “Say there's 10,000 uncured or poorly suboptimally treated human diseases.” At the current pace of drug development, it might take about 200 years to create treatments for those conditions. “Imagine if we could 10x that,” Longmire says. Join us for the next episode of DeviceTalks AI, where we sit down with Ha Hong, PhD, Chief Artificial Intelligence Officer, Endoscopy at Medtronic. Thank you to our sponsors Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. catalyzehealthcare.com smarttrak.com Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH, LISTEN, and READ: https://www.drugdiscoverytrends.com/when-will-drug-development-have-its-chatgpt-moment-inside-ambitious-ai-initiatives-at-sanofi-and-medable/ Thank you for supporting DeviceTalks AI!…
1 With $57m secured, CEO Fain Details Next Move for pMCS startup Procyrion; What’s Moonshot’s Mission 54:27
54:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
54:27In this week’s episode, Procyrion CEO Eric Fain details the next steps for the startup’s ambitious plans to secure FDA approval for Aortix, a percutaneous mechanical circulatory support (pMCS) device being developed for patients with acute decompensated heart failure (ADHF) who remain congested despite standard medical therapy (cardiorenal syndrome or CRS). Fain will talk about raising the company’s recent $57.7 million round. He’ll also share some lessons from his successful career as an executive at larger medical device companies. In the opening discussion, Co-Hosts Tom Salemi and Chris Newmarker talk with Santosh Iyer, CEO and Founder of Moonshot, a summer program for high school students interested in learning how the Medtech industry uses cool tech to save lives. For more information visit Moonshot.school. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.…
1 How do I get a medical device in front of the right people? with Nicole Osmer 29:21
29:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:21In the latest episode of MedtechWOMEN Talks, Nicole Osmer, Founder & CEO at Health+Commerce, shares her expertise on the role of branding, media relations, and public relations in the medical device product development cycle from the perspective of “The Publicist.” In the episode, Osmer shares the significance of establishing a strong brand right from a company's inception. Attention to detail in messaging, brand presence, and even the subtleties like an area code on a contact page are pivotal. A central theme revolves around structuring communication effectively through traditional and emerging media channels to make significant market impacts. Osmer's insights on press releases, direct media outreach, and the role of digital platforms offer valuable takeaways on modern medtech marketing. The episode covers not only the 'what' but also the 'how' of successful medtech communications. TL;DR – Key takeaways: 1. Establishing a strong brand from the early stages and maintaining it throughout the lifecycle of a medtech company is crucial for lasting success. 2. Clear, concise messaging and being prepared for media opportunities with key story elements is essential in PR and branding. 3. Press releases remain a relevant tool for communication, especially when they are concise, impactful, and include a compelling headline. 4. Collaboration across various company functions such as marketing, clinical teams, and investor relations is integral to a coherent communication strategy. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support. https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretexmedical.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.…
1 Medtronic’s Jason Weidman recalls the long, bumpy road to getting FDA approval for Symplicity Spiral 1:03:12
1:03:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:12This week’s DeviceTalks Weekly is a bit of a retrospective on Medtronic’s Symplicity Spiral Renal Denervation System. It obviously ends on a happy note, and we’ll catch up with Jason Weidman, SVP and president of Medtronic’s Coronary and Renal Denervation business in an interview conducted in January. Thank you to AcuityMD for sponsoring this podcast. www.acuityMD.com. Weidman talked with Co-Host Tom Salemi last month to recap a bit of a history of the program including the dramatic – and successful – conclustion at the FDA. We also draw from an earlier interview Weidman gave to our MedtronicTalks Podcast in 2021. Together, these clips and interviews reflect the time and dedication that ambitious medtech programs require. In the current interview, Weidman also give a glimpse of renal denervation’s future. Other resources Medtech Talk Podcast - https://medtechmvp.com/media/medtech-talk-podcast/Mark-Gelfand-Howard-Levin-Discuss-Coridea-Ardian-and-How-They-re-Innovating-Medtech-Innovation 2021 MedtronicTalks Podcast with Jason Weidman - https://www.devicetalks.com/weidman-talks-us-through-the-long-road-to-ge Co-Host Chris Newmarker, executive editor of MassDevice, also discusses his new article – 10 Surgical Robotic Companies that You Need to Know. https://www.massdevice.com/10-surgical-robotics-companies-you-need-to-know-2024/ Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.…
1 J&Js Tezel Says Tapping Global Network and Diverse Engineering Disciplines Strengthens Medtech R&D 1:24:07
1:24:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:24:07We’ll open this week’s episode with Paul Grand, CEO of the MedTech Innovator. Grand issued a last call for medical device entrepreneurs to apply to be part of this year’s program. Lots of good stuff come with it. Listen to the episode and apply at MedTechInnovator.org. Then Co-Hosts Tom Salemi and Chris Newmarker interview successful startup CEO Bill Gruber about his new book, The Leadership Blueprint. Gruber shares some experiences and lessons, but entrepreneurs are encouraged to buy the book on Amazon. Finally, Tom Salemi interviews Ahmet Tezel, Company Group Chairman and Global Head of J&J MedTech Innovation and R&D about his path into medtech and what the future holds for Johnson & Johnson and the medical device industry. Thank you to the sponsor of this episode – Tecan. Here’s a message - Tecan brings all the healthcare OEM pieces together with fully integrated solutions across the entire MedTech and life sciences spectrum from idea to implementation. Partner with us to revolutionize the way you develop medical technology with the Emphysys approach and turn your visionary ideas into a tangible reality in a matter of months, not years. www.emphysys.com/ Thank you for listening to the DeviceTalks Podcast Network. Subscribe now to the DeviceTalks Podcast Network.…
1 GE HealthCare pulls back the curtain on its unmatched AI clearances; Catalyze tackles AI trust gap 49:17
49:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
49:17This episode of DeviceTalks AI emphasizes the prognostic and point-of-care decision-making power of AI in oncology while addressing real-world implementation issues from regulation and liability to clinician trust and adoption, through conversations with leaders at GE HealthCare and Catalyze Healthcare. In the first segment, Ben Newton, General Manager of Oncology at GE HealthCare describes likely future advances in multimodal computing, which could parse diverse datasets from pathology, imaging, genomics and other domains to predict likely outcomes in given treatment scenarios. Newton also emphasized AI's ability to help overwhelmed physicians by alleviating workflow bottlenecks and assisting with point-of-care decision making. Despite the promise, he underscored that such advances rely on incorporating clinicians’ valuable perspective when developing these AI systems and partnerships with other industry stakeholders, such as cloud partners like AWS and academic centers or hospitals, to access data and create foundation models. In the second segment, Haley Schwartz, CEO at Catalyze Healthcare, highlights the potential of using AI for screening applications as an initial stepping stone to build trust and adoption. She also notes that potential headwinds for hospital adoption of AI are questions related to legal liability and reimbursement impacts. In addition, Schwartz emphasizes the importance of physician involvement, especially during the early stages of AI integration into healthcare. Join us for the next episode of DeviceTalks AI, featuring a keynote interview with Helen Merianos, Head of Sanofi’s R&D Portfolio Strategy. Thank you to our sponsors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. www.catalyzehealthcare.com www.smarttrak.com Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH, LISTEN, and READ. Thank you for supporting DeviceTalks AI! Read Now: https://www.medicaldesignandoutsourcing.com/ai-holy-grail-devices-disease-digital-healthcare/ Watch Now: youtu.be/XtGbJ-2Jyro…
1 Fluidda’s De Backer, FastWave’s Nelson Share Individual Strategies for Breaking into Medtech Markets 1:12:24
1:12:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:12:24In this podcast we’ll talk with two CEOs scaling tall Medtech mountains. First, co-hosts Chris Newsmarker and Tom Salemi chat with Jan De Backer, CEO of Fluidda, developer of a novel new diagnostic tool for respiratory health. De Backer explains how his company is trying to bypass hospitals and build a new commercial path to patients. Then, Salemi talks with Scott Nelson, CEO of FastWave Medical, an innovative new company developing a new intravascular lithotripsy device. How does the start-up intend to compete with market leader Shockwave Medical? Thank you for listening to this episode of the DeviceTalks Weekly Podcast Don’t miss a future episode. Subscribe to the DeviceTalks Podcast Network.…
1 Boston Scientific Jones and Dunkin detail why Apollo tech could launch endosurgery revolution 38:02
38:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
38:02This episode of Boston Scientific Talks features Boston Scientific's entrance into advanced endoluminal surgery and obesity management, spearheaded by its acquisition of Apollo Endosurgery in November 2022. Chief Medical Officer, Endoscopy Brian Dunkin, MD and SVP and President, Endoscopy Mike Jones explore the strategic value of this acquisition and the integration of Apollo's technology, which is poised to potentially revolutionize endoscopic procedures. The discussion centers on the potential of Apollo's technology in broadening Boston Scientific's endoluminal surgery capabilities. Jones highlights the addition of the Overstitch device, which enhances the company's ability to perform endoscopic suturing and endoluminal sleeve gastroplasty, addressing obesity through minimally invasive means. Additionally, Dr. Dunkin provides a clinical perspective on how these technologies represent a paradigm shift in surgery, moving towards scarless operations. They also explore the role of GLP-1 medications in the medical device market, underlining how pharmaceuticals complement devices in obesity treatment. The episode gives a comprehensive view of Boston Scientific's strategy in integrating Apollo's technology into its portfolio, the challenges of training and adoption, and the optimism for future innovations in minimally invasive procedures. Thank you to Freudenberg Medical for sponsoring this episode. Please visit Freudenberg Medical’s dedicated webpage at https://www.freudenbergmedical.com/en/single-use-scopes/ to learn more about their specific expertise in this area and to access Freudenberg Medical’s trend paper on the topic. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform, https://linktr.ee/DeviceTalks…
1 Unpacking the 20 Years of Innovation, Engineering and Execution That Has Built MitraClip’s Success 50:39
50:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
50:39In this special episode of AbbottTalks, recorded live from DeviceTalks West in October 2023, we celebrate a pivotal moment in medical innovation: the 20th anniversary of Abbott's MitraClip™, a revolutionary device introduced in 2003. In the episode, the inventor of the MitraClip, Frederick St. Goar, MD, Interventional Cardiologist, El Camino Health, and Abbott's Santosh Prabhu, PhD, Divisional VP, Global Product Development, discuss the journey of the MitraClip, reflecting on its inception, evolution, and lasting impact on cardiac care over the past two decades. Dr. Goar provides insights into the early challenges and motivations behind inventing the MitraClip, emphasizing its role in transforming minimally invasive cardiac procedures. He reflects on the initial concept, design iterations, and clinical experiences with the device. Dr. Prabhu discusses the continuous enhancements made to the MitraClip since its inception, focusing on improved safety, efficacy, and usability. He highlights the MitraClip's role in reducing hospitalizations and improving patient outcomes, as evidenced by the five-year results from the landmark COAPT™ trial. The episode pays tribute to the legacy of the MitraClip, acknowledging its significant contribution to medical technology and patient care and emphasizing the importance of interdisciplinary collaboration and patient-centric approaches in medical innovation. Thank you to Zeus for sponsoring this episode of AbbottTalks. For more information about Zeus go to www.ZeusInc.com. Thanks for listening to this episode of the AbbottTalks podcast. Please subscribe to the DeviceTalks Podcast Network. COAPT Trial Release -https://abbott.mediaroom.com/2023-03-05-Late-Breaking-Data-from-Landmark-COAPT-TM-Trial-Show-Long-Term-Benefits-of-Abbotts-MitraClip-TM-Device MitraClip History - https://www.abbott.com/corpnewsroom/products-and-innovation/the-mitraclip-story.html#:~:text=MitraClip's%20story%20starts%20in%20California,The%20idea%20was%20unheard%20of.…
1 How do I get funding for my medical device? with Vivian Golfin, Intuitive Ventures 27:21
27:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
27:21In the latest episode of MedtechWOMEN Talks, Vivian Golfin, MD, Senior Associate at Intuitive Ventures, shares her expertise on the role of venture capitalists in the medical device product development cycle from the perspective of "The Venture Capitalist." In the episode, Dr. Golfin discusses the significance of early engagement with venture capital firms for startups and how Intuitive Ventures acts as a strategic partner rather than just a financier. She emphasizes the detailed due diligence process, focusing on understanding the risks and potential of medical device startups. Key topics include the importance of milestones like first-in-human trials, early pilot results, and the necessity of feedback in the development process. Dr. Golfin also addresses the evolving role of AI and ML in medical devices and the importance of data diversity. Her insights highlight the need for proactive communication, networking, and leveraging AI for health equity. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support. https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks!…
1 Will 2024 Bring Medtech More Promise or More Pain? HSBC’s Norris on Investments, Investors and Exits 53:55
53:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
53:55In the first episode of 2024, co-hosts Tom Salemi and Chris Newmarker bring Jonathan Norris, managing director of HSBC Innovation Banking, into the booth to review the medtech portion of the HSBC Venture Healthcare Report. Last year wasn’t medtech’s strongest, but Jon Norris gives entrepreneurs actionable advice and reason for hope. You can find the entire report on the Linked. Check the feed of Norris and Salemi for a link to the report. Or go here https://www.linkedin.com/feed/update/urn:li:activity:7148682579204800512/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of our many great shows.…
1 Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A 44:46
44:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:46In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses. In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office. Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth. Thank you to our season one sponsors, AcuityMD and Millstone Medical for supporting this podcast. To learn more about our episode sponsor, AcuityMD, please visit http://acuitymd.com. Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!…
1 It’s the Big One! Hear our Media Roundtable Debate and Discuss the Top Medtech Newsmakers of 2023 55:52
55:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:52In our final DeviceTalks Weekly of the year, the news team assembles to highlight MassDevice’s Top Medtech Trends of 2023. Let us know if you think we missed something, but we think we recorded all the hits. Thank you for being part of DeviceTalks! We look forward to sharing YOUR stories in 2024. Happy New Year and Go Medtech! Thank you for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.…
1 The episode where we discover data’s hidden gems with Microsoft and Sam Altman-backed 1910 Genetics 1:00:10
1:00:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:10This episode of DeviceTalks AI explores the potential for data-driven innovation in healthcare, through conversations with leaders at Microsoft and 1910 Genetics. In the first segment, Elena Bonfiglioli, Global Business Leader for Healthcare, Pharma and Life Sciences at Microsoft, discusses the significance of computation, an essential element of AI investments, in enhancing R&D productivity in healthcare. She emphasizes the need for new approaches to drug development, including shorter clinical trial timelines and the shift toward more efficient R&D. Bonfiglioli also highlights the importance of multimodal data in research and development. In addition, speaks to the integral role of computational methods in drug development, emphasizing how they augment our disease understanding and clinical trial design. In the second segment, Jen Nwankwo, PhD, Founder & CEO of 1910 Genetics - a Y Combinator and Sam Altman-backed startup, shares the innovation strategies around drug discovery. She details their problem-first approach, leading to an integrated, modality-agnostic drug discovery tech stack. Dr. Nwankwo highlights the use of Azure Quantum Elements in accelerating molecular simulations, positioning 1910 Genetics uniquely in designing both small and large molecules. Their global approach to accessible drug discovery through strategic partnerships is emphasized. Join us for the next episode of DeviceTalks AI, featuring an exclusive interview with Ben Newton, Chief Digital Officer and GM of Oncology at GE Healthcare. Thank you to our contributors, some of whom include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing invaluable support. Tune in and subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH, LISTEN, and READ. Thank you for supporting DeviceTalks AI! Read Now: www.drugdiscoverytrends.com/microsoft-1910-genetics-data-hidden-gems…
1 CEO Richards Helps Us See Elucid more clearly; A Chat with Newsmaker Canary Medical CEO Bill Hunter 1:08:00
1:08:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:00In this episode, we’ll talk with Medtech Industry Veteran Bill Hunter about the state of Medtech. The CEO of Canary Medical, a leader in medical device sensor technology and data collection, draws lessons from his long career in the industry, sharing his victories and a moment he had previously considered a defeat. Be sure to follow Bill Hunter on LinkedIn. Then, CEO Blake Richards introduces us to Elucid, which developed a software as a service company that can help physicians to better determine the severity of vascular disease. How did Elucid raise over $100 million and venture capital, and what new policies will bolster its bottom line. Thanks for listening to the DeviceTalks Weekly Podcast. Please subscribe to the DeviceTalks Podcast Network.…
1 How do I design, verify and validate a medical device? With Kathryn Rieger, Intuitive 29:21
29:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:21In the second episode of MedtechWOMEN Talks, our guest Kathryn Rieger, PhD, Sr. Director, Human Factors & User Research at Intuitive, shares her insights on the medical device product development cycle from the perspective of "The Engineer." Drawing from her unique background in military tech and auto tech and her extensive experience in medtech, Dr. Rieger shares insights into how engineers influence the essential stages of the medical device product development cycle. In the episode, Dr. Rieger emphasizes the rigorous nature of verification and validation processes in medtech, underlining the importance of document control and thorough testing to ensure device safety and functionality. She also highlights the role of clinical studies in pre-market validation, underlining the significance of balancing safety considerations with regulatory compliance. Additionally, Dr. Rieger discusses the growing role of AI and machine learning in optimizing development processes while prioritizing user needs and safety. TL;DR - Key takeaways: 1. Integrating user experience and safety is crucial in medical device development. 2. A multidisciplinary approach to medtech product development is key. 3. Effective collaboration and communication are critical to successful product launches. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical for providing vital support. aptyx.com catalyzehealthcare.com confluentmedical.com cretex.com Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks!…
1 How AVS’ PIVL system could compete in growing PAD market; Details on Medtech’s new digital playbook 43:11
43:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:11In this episode we’ll talk with Sean Gilligan, chief operating officer at AVS (Amplitude Vascular Systems), about that company’s big play in intravascular lithotripsy, the approached pioneered by vascular leader Shockwave Medical. Gilligan gives some detail on the company’s new approach and shares some insights from his own career as well. We also visit with Steve Levine, Sr. Director, Virtual Human Modeling, and Afrah Shafquat, Senior Data Scientist, both of Dassault Systemes, which sponsored this episode. The pair shared insights on what medical device companies can expect to see from a new set of guidelines being issued for digital simulations in Medtech regarding in silico clinical trials. For more information go to https://www.3ds.com/industries/life-sciences-healthcare/medical-device. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.…
1 Boston Scientific's Paudie O'Connor on managing supply chain volatility and sustainability 25:50
25:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
25:50In this episode of Boston Scientific Talks, Paudie O'Connor, SVP of Global Supply Chain, reflects on how Boston Scientific is overcoming initial supply chain challenges by establishing a new operational efficiency and sustainability standard. Additionally, O'Connor highlights Boston Scientific's strategic shift towards more sustainable practices, including a significant reduction in carbon footprint by transitioning from air to ocean freight, reducing carbon footprint by 96%, and aiming for a 90% ocean freight rate by 2026. This shift necessitates infrastructural investments, such as building sterilization facilities closer to manufacturing sites, enabling direct market shipping, and transitioning from air to sea where feasible. The discussion also covers innovations in packaging, with a move towards digital instructions and tailored packaging for different markets. This approach aligns with environmental goals while catering to diverse regulatory requirements. Lastly, O'Connor speaks to the role of supplier partnerships in achieving these ambitious targets, underlining Boston Scientific's commitment to not only navigating but also redefining the supply chain norms in the medical device industry. Listen to this episode of the DeviceTalks Weekly Podcast to hear more about Paudie O'Connor's career and work at Boston Scientific. https://www.devicetalks.com/what-boston-scientifics-evolving-supply-chain-strategy-means-for-partners-productivity-and-ma/ Thank you to Xometry for sponsoring this episode. Visit www.xometry.com to learn more about Xometry and get an instant quote or injection molding quote today. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.…
1 Stryker’s neurovascular president Jim Marucci on Cerus acquisition, Target Tetra and AI/AR potential 30:51
30:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
30:51In this episode of StrykerTalks, neurovascular president Jim Marucci discusses the company's latest advancements in neurovascular technology and how that, and its expanding global footprint, are shaping the future of its neurovascular division. Marucci details the company's recent strategic acquisition of Cerus Endovascular, which has increased Stryker's capabilities in treating wide-neck bifurcated aneurysms. Furthering Stryker's goal to simplify procedures, reduce costs, and improve patient outcomes. The conversation also touches on developing new products like the Target Tetra detachable coil for smaller aneurysms and the potential of emerging technologies like AI, AR, and VR in neurovascular procedures. Marucci anticipates these technologies will play a crucial role in advancing the field and improving access to care globally. Tune in for a comprehensive overview of Stryker's current strategies, product innovations, and future directions in the neurovascular sector, underlining its commitment to enhancing stroke care and neurovascular treatments worldwide. Thank you to Zeus for sponsoring this episode. To learn more about how Zeus works with medical device companies, visit www.zeusinc.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on every major podcast platform.…
1 How do I Drive Medtech Product Development? With Kirsten Carroll, Kandu Health 31:53
31:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
31:53In the first episode of the newest series from the DeviceTalks Podcast Network, our guest Kirsten Carroll, CEO of Kandu Health shares her insights on the medical device product development cycle from the perspective of "The Product Director." With more than a decade and a half in product management for Boston Scientific and Stryker Neurovascular, Kirsten discusses the roles of product management, design verification, and design validation in ensuring a successful product launch. She also highlights the significance of generating clinical evidence and tailoring it to different stakeholders. Kirsten's key message is the value of effective communication and collaboration in developing and launching medical devices. TL;DR Key take-aways: 1. Collaboration between different teams is crucial in the medical device product development cycle. 2. User needs should be clearly defined and translated into specifications for design verification. 3. Design validation involves testing the product with the intended users to ensure it meets their expectations. 4. Clinical evidence generation should align with the specific needs of different stakeholders. 5. Effective communication and collaboration are essential for successful product development and launch. Thank you to our sponsors Aptyx, Catalyze Healthcare, Confluent, and Cretex Medical for providing vital support. aptyx.com catalyzehealthcare.com confluentmedical.com cretex.com Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for supporting MedtechWOMEN Talks.…
1 Does Medtech Need a New Way? Hear from Imperative Care’s Fred Khosravi, McKinsey’s Delphine Zurkiya 1:13:57
1:13:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:57In this episode, we’ll hear from Fred Khosravi, CEO of Imperative Care, a medical device company that is taking an unusually holistic approach to helping people who have suffered strokes. Host Tom Salemi interviewed the successful medical device CEO at DeviceTalks West. Before that we’ll talk with Delphine Zurkiya, senior partner at McKinsey & Co., about a new report that lays out a blueprint for medical device companies to improve efficiencies in R&D and customer outreach. But first we’ll highlight our newest member of the DeviceTalks Podcast family – AI Meets Life Sci – with co-hosts Kayleen Brown and Brian Buntz! Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 The episode where Mayo Clinic & Anumana transform ECG with AI; ConcertAI dishes on next-gen trials 1:07:46
1:07:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:07:46Welcome to DeviceTalks AI, a DeviceTalks podcast offering a comprehensive look into the intersection of AI and the medical device industry from two unique perspectives. In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible medical devices. In the second segment, Jeff Elton, PhD, CEO of ConcertAI, speaks to the transformative role of AI in clinical trials. He sheds light on AI's capabilities in improving patient selection for clinical trials and streamlining processes within life sciences. Dr. Elton emphasizes the broader implications of AI, from enhancing patient care to accelerating the development of new treatments, and discusses the ethical considerations of AI integration in healthcare.These interviews provide insights into the evolving roles of AI in various sectors like medtech, pharma, and biotech, showcasing its potential in transforming healthcare and research methodologies. But that's not all! Join us for the next episode of DeviceTalks AI, which features an interview with the Global Business Leader for Health and Life Sciences at Microsoft. Catch the full episode on all major podcast platforms and the DeviceTalks YouTube to dive deeper into the exciting convergence of AI and medtech. Thank you to our contributors, some of who include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing vital support. To learn more about our contributors, visit: www.catalyzehealthcare.com and www.smarttrak.com. Thank you for listening to DeviceTalks AI.…
1 Hear Why J&J Medtech Is Ready to Move Forward with Ottava; A VC Discusses the Impact of GLP-1 drugs 1:02:55
1:02:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:55In this week’s episode we’ll speak with Rocco De Bernardis, Global President of OTTAVA, Johnson & Johnson MedTech. This week, J&J MedTech announced it was filing an IDE to begin clinical trials on its surgical robotics system, Ottava, in 2024. But what does this mean? What does Ottava look like? Why does J&J MedTech think it has what it takes to win over surgeons? And what does the future look like for the company’s surgical robotics platform? Co-hosts Tom Salemi and Chris Newmarker also chat with Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, about the impact GLP-1 drugs could have on medical device start-ups. How does Gilde see the weight loss drugs impacting its portfolio and future investments? Finally, Gregg Tobin, CEO of Aptyx, our episode sponsor, talks about how the company’s new name better reflects its capabilities. Go to Aptyx.com for more information. Thanks for listening to the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 Boston Scientific's EP leaders Stein and Spadea-Anello discuss the next leap in cardiac ablation 43:29
43:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:29In this episode of Boston Scientific Talks, Boston Scientific's electrophysiology leaders, Ken Stein, MD, SVP, Global Chief Medical Officer and Nick Spadea-Anello, Global President of Electrophysiology, offer a deep dive into the transformative potential of the FARAPULSE Pulsed Field Ablation System. They discuss the strategic development and clinical advantages of this innovative technology, emphasizing its ability to target cardiac tissue while minimizing the risk of collateral damage to vital structures like the esophagus. The duo also explores the synergistic potential of combining PFA with devices like the WATCHMAN for stroke prevention, painting a picture of a more streamlined, patient-centric approach to cardiac care. With a keen eye on the future, they discuss the vision for expanding PFA's applications, including its role in treating a broader spectrum of arrhythmias and its adaptability to various procedural settings. Tune in to learn more about Boston Scientific's forward-thinking approach to cardiac ablation. Thank you to Dassault Systèmes for sponsoring this episode. To learn how Dassault Systèmes enables innovation in medtech, visit www.medtecheco.com/lifecycle. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.…
1 Intuitive's Dave Rosa shares insights on surgical robotics’ evolution, offers advice to new players 38:49
38:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
38:49In this special episode of IntuitiveTalks, recorded live from DeviceTalks West, Dave Rosa, President of Intuitive, shares the experience of the company's pioneering role in surgical robotics. Rosa reflects on the initial skepticism faced by the company and the subsequent validation of their work as the industry has grown to embrace robotic assistance in surgery. He also discusses the balance between innovation and the practicalities of scaling a business, emphasizing the importance of reliability and supply chain management in healthcare technology. Rosa also addresses the future of surgical robotics, hinting at a shift towards more compact and specialized devices that could transform patient care. He highlights the economic benefits of robotic surgery, particularly its potential to reduce the overall costs of healthcare while improving surgical outcomes. A must for all medtech stakeholders, this episode offers a thoughtful perspective on leading a company at the forefront of medical technology. Rosa's conversation is a blend of personal experience and professional insights, providing valuable lessons on growth, adaptation, and the continuous effort to improve surgical care. Thanks to maxon Group for sponsoring this episode. Visit https://www.maxongroup.us/maxon/view/content/medical to learn more about how maxon Group works with medical device companies. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.…
1 Abbott’s Tyler outlines vascular’s move to predictive modeling, diversifying trials & next-gen tech 59:07
59:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
59:07In this special episode of AbbottTalks, recorded live from DeviceTalks West, Julie Tyler, president of Abbott's Vascular business, discusses the company's strategic evolution and commitment to comprehensive patient care, including a new technology, the Esprit BTK, intended to be released next year. Additionally, Tyler provides an insider's perspective on Abbott's integration of Cardiovascular Systems Inc., revealing how this move enhances Abbott's portfolio and positions the company at the forefront of vascular health. Tyler's vision extends beyond current interventions, aiming to leverage data and predictive modeling to improve patient outcomes and potentially reduce the need for later-stage interventions. With a patient-centric approach, Tyler also discusses the challenges and successes in diversifying clinical trial demographics and expanding global reach. This episode is a must-listen for those interested in how strategic acquisitions and a holistic health model can redefine patient care. Thank you to Resonetics for sponsoring this episode. To learn more about how Resonetics works with medical device companies, visit https://resonetics.com/. Thank you for listening to the AbbottTalks Podcast. Subscribe to this podcast on every major podcast platform.…
1 Qiagen CEO on learning to love diagnostics and why he’s worried we forgot lessons from the pandemic 56:53
56:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:53In this week’s episode, Qiagen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently released Women in Medtech issue of Medical Design and Outsourcing magazine. Kirsh shares data she’s collected on how many women hold senior positions in the medical device industry. We’re seeing some progress, but not enough. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.…
1 It’s the DeviceTalks West Post Game Wrap Up Show, Starring Tom, Chris, Kayleen, Sean and Joe!! 43:25
43:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:25We recorded this episode on stage at the conclusion of DeviceTalks West. Our semi-esteemed panel included Co-Hosts Tom Salemi and Chris Newmarker as well as Sean Whooley of the Fast Five Podcast, Kayleen Brown of DeviceTalks, and Joe Mullings of The Mullings Group. We hit upon the highlights of DeviceTalks West. We hope you were there to enjoy the show yourself! Thanks to everyone who made #DTWest2023 such a huge success! Go Medtech!…
1 Join us at DeviceTalks West on Oct. 18-19! A pre-interview interview with Intuitive’s Dave Rosa 40:39
40:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
40:39Join us at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center! In this episode, Tom Salemi invites all DeviceTalkers to our biggest West Coast meeting yet! Listen for the discount code (Oh heck, it’s DTW25). We’ll also run a replay of our interview with Dave Rosa, now president of Intuitive, who will be our opening keynote interview on Oct. 19. Register now at West.DeviceTalks.com! GO MEDTECH!…
1 How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical 39:57
39:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
39:57A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you’ll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD. Salunke will also be a speaker at the upcoming DeviceTalks West meeting. Thanks for listening to this episode of DeviceTalks Weekly. Subscribe to the DeviceTalks Podcast Network on any major podcast channel.…
1 Boston Scientific's Sandra Nagale predicts the future of medtech powered by AI innovations 35:57
35:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:57In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device industry. Motivated to drive impactful changes, Nagale emphasizes Boston Scientific's unwavering dedication to pioneering breakthrough medical solutions and enhancing patient and physician experiences through AI and emphasizes how products like BeatLogic and LUX-Dx ICM are redefining healthcare by providing actionable, real-time insights. Navigating the complexities of melding AI with healthcare, Nagale accentuates the necessity for solutions rooted in evidence that genuinely amplifies value. She highlights the urgency to streamline patient experiences, mitigate healthcare worker challenges, and elevate the patient journey. As Boston Scientific spearheads these advancements, Nagale envisions a future where medical devices seamlessly integrate into holistic patient care – from early detection to treatment. Dive into this episode to uncover how Boston Scientific is steering the medtech industry into an AI-augmented future. Thank you to S3 Connected Health for sponsoring this episode of Boston Scientific Talks. For more information about S3 Connected Health, go to s3connectedhealth.com. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.…
1 Hear the Last 10 Start-ups Standing in MedTech Innovator’s Pitch Competitions 1:15:10
1:15:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:15:10This week’s episode is dedicated entirely to the 10 Finalists of MedTech Innovator’s Pitch Competitions. The final winners will be selected by the audience on Oct. 10 at the upcoming AdvaMed annual meeting. The finalists for MedTech Innovator’s grand prize of $350,000 are listed below. Click on the link to watch their 1-minute pitch video. Dr. Tom McClellan - Fingy3D - https://www.youtube.com/watch?v=KCoj_ZALf3c Amanda French - IFPx - https://www.youtube.com/watch?v=8B3j2weOkNo Jay Shah/Vivek Ganesh - Neurava - https://www.youtube.com/watch?v=lyUB9WCLeww Dr. Alex Woods - Newrotex - https://www.youtube.com/watch?v=MEhP_Ack32c Alex Ballatori/Shane Shahrestani - StrokeDx - https://www.youtube.com/watch?v=tdkl5QyDfD8 The companies listed below are vying for MedTech Innovator’s Execution Award. The winner will receive $25,000. Click on the link to watch their 1-minute pitch video. Harlee Sorkin - InterShunt Technologies - https://www.youtube.com/watch?v=QPi5FSRSjUQ Michael Ebner - Hypervision Surgical - https://www.youtube.com/watch?v=oTz-AXfwJgw Lori Arakaki - Opticyte - https://www.youtube.com/watch?v=AECmlLpv0hE Joanna Nathan - Prana Thoracic - https://www.youtube.com/watch?v=myjUp3Gg4mQ Dushyanth Surakanti - Sparta Biomedical - https://www.youtube.com/watch?v=wvS9PwpkT_c DeviceTalks’s Tom Salemi and Kayleen Brown visited with the founders and CEOs of each of the 10 companies. We’ll run through those interviews with Paul Grand, CEO of the MedTech Innovator program. Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 Ryan Lakin dives into Abbott's pioneering role in digital health and patient engagement 44:52
44:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
44:52In the newest episode of AbbottTalks, Ryan Lakin, Divisional Vice President of Digital Solutions, Medical Devices at Abbott, delves deep into the transformative role of digital health solutions in the medical device landscape and emphasizes Abbott's commitment to not just treating the sick but also empowering individuals to maintain optimal health. Lakin shares insights into how Abbott's innovative technologies, like the FreeStyle Libre 2 glucose monitoring system and Lingo, are reshaping patient care by offering real-time data and insights. This proactive approach allows patients to understand their body's reactions to various stimuli, leading to more informed health decisions. Lakin also touches on the challenges of integrating digital tools into healthcare, highlighting the need for evidence-based solutions that genuinely add value. He underscores the importance of simplifying patient pathways, reducing healthcare worker burdens, and enhancing overall patient experiences. As Abbott continues to pioneer in this realm, Lakin speaks to a future where medical devices play a more holistic role in patient care, from prevention to intervention. Listen today to hear more on how Abbott is shaping the future of digital health. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the AbbottTalks Podcast.…
1 CEO Clifford on how Moximed has kept singularly focused on developing a shock absorber for the knee 1:00:43
1:00:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:43Osteoarthritis isn’t a typical target for startups but Moximed isn’t developing a typical device. In this episode, CEO Anton Clifford will walk us through the biomedical process that led to the decision to build a shock absorber that can stabilized an injured knee. The route been long, winding and has led the team over some bumpy roads but Moximed is poised to deliver on its long-time promise. At the start,co-hosts Tom Salemi and Chris Newmarker chat with Associate Editor Sean Whooley about Boston Scientific’s recent analyst day, with a tight focus on why Boston Scientific sees opportunity in China when other medical devices are withdrawing. Notes for this episode https://www.massdevice.com/boston-scientific-targets-next-level/ https://www.medicaldesignandoutsourcing.com/china-exposure-medtronic-intuitive-henry-schein-align-envista-dentsply-sirona/ https://www.massdevice.com/zimvie-reports-difficult-macroenvironment-q4-miss/ https://www.massdevice.com/category/massdevice-podcast/ Thanks for listening to the DeviceTalks Weekly Podcast Subscribe to the DeviceTalks Podcast Network on any major podcast player.…
1 Intuitive's Tony Jarc discusses the next leap in surgical robotics with AI integration 38:41
38:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
38:41In this episode of IntuitiveTalks, Tony Jarc, Sr. Director of Digital & Machine Learning at Intuitive, walks us through the evolving landscape of surgical robotics, highlighting the transformative potential of AI and machine learning in enhancing surgical procedures, providing real-time guidance to ensure the best possible patient outcomes. Jarc also introduces Case Insights enabled by the My Intuitive hub, a digital tool designed to offer surgeons valuable post-operative feedback. But the platform's potential goes beyond the data. Jarc also underscores the significance of collaborating with surgeons from the early stages of product development to ensure its useability and effectiveness. As surgical robotics continue to advance, Jarc's insights provide a glimpse into how technology and human expertise can work in tandem for improved surgical procedures. Listen now to learn more about how Intuitive is not just embracing the intersection of AI and surgical robotics but using it to guide future opportunities. Thank you to TECAN, for sponsoring this episode of IntuitiveTalks. Visit tecan.com/paramit-design-to-manufacturing to hear from TECAN’s leadership team in an expert video series and to download TECAN’s Product Requirements Checklist to help you prepare for your product development. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.…
1 Hawkins on how Avail is changing Medtech; Turning Pain into Purpose & other MedtechVision Takeaways 1:13:10
1:13:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:13:10This week we’ll visit with Daniel Hawkins, CEO of Avail Medsystems. Hawkins is a prolific and successful medtech entrepreneur who was an early employee at Intuitive and co-founder of Shockwave Medical. Hawkins talks about both experiences, but DeviceTalks listeners should listen carefully for his insights on how ASCs are changing medtech and how OEMs are using Avail’s telepresence system to compensate. DeviceTalks Editorial Director Tom Salemi and Managing Editor Kayleen Brown share their takeways from the MedtechVISION conference in Menlo Park. The conference raised many themes that we’ll be exploring at DeviceTalks West on October 18-19 at the Santa Clara Convention Center. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on many major podcast player.…
1 Synchron’s Haggstrom delivers a taste of what he’ll be sharing on neural tech at DeviceTalks West 39:45
39:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
39:45In this week’s episode, medical device pro Kurt Haggstrom details what led him to join high-flying neural implant company Synchron, which is one of the companies in a supposed race to create a direct link to the brain. Haggstrom will be sharing even more details at DeviceTalks West on Oct. 18-19 at the Santa Clara Convention Center. But today’s episode will give a sample of why he sees Synchron changing the world as it works to unlock “the natural highways of the brain.” We’ll also talk about the value of good engineering and marketing in medical devices. Find out more about Synchron here. https://synchron.com/ Executive editor Chris Newmarker joins us to discuss this week’s news that Philips reached a partial settlement in its class-action suit over sleep apnea machine recall. This isn’t the end of the story. To read all about the recall go here. https://www.massdevice.com/how-philips-significant-respiratory-devices-recall-unfolded/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 CEO Nahum explains how Quantum Surgical is positioned for robotic surgery’s next evolutionary stage 1:03:45
1:03:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:45This isn’t Bertin Nahum’s first surgical robotics rodeo. The CEO of Quantum Surgical previously co-founded, led and ultimately sold surgical robotics pioneer Medtech S.A. to Zimmer Biomet. Now, he’s leading several members of that founding team as Quantum Surgical develops a next generation of surgical robot to enable easier removal of cancerous tumors. Nahum brings great insight and perspective to the topic of surgical robotics, which is why he’ll sit on a panel of surgical robotic company CEOs and provider represents to discuss what surgical robotic systems of the future may look like. Register at DeviceTalks.com. Joining co-hosts Chris Newmarker and Tom Salemi is Danielle Kirsh, senior editor of MassDevice, to review a few of the highpoints of the current Medical Design and Outsourcing issue of the Big 100. We’ll talk about headcounts, R&D spends and CEO salaries. You can find the issue of the Big 100 here. https://www.medicaldesignandoutsourcing.com/september-2023-medtech-big-100-largest-device-companies/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 Andrés Rosales talks Stryker's FDA wins with 1788 visualization and SPY-PHI technology 32:01
32:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
32:01In this episode of StrykerTalks, Andrés Rosales, VP and General Manager Endoscopy, delves into Stryker's groundbreaking 1788 visualization platform and and its potential to revolutionize surgical procedures. The 1788 visualization platform, Stryker's 26th generation camera, enables surgeons to see more so they can do more by visualizing tissue perfusion and illuminating cancer cells, ultimately improving patient outcomes. Rosales also discusses the newly 510(k) cleared SPY-PHI for lymphatic mapping within breast cancer, offering surgeons a more efficient and patient-friendly alternative to traditional radioactive markers. The innovation continues as Rosales hints at the future of Stryker's technology, emphasizing the role of data collection and algorithm development in improving surgical procedures. Tune in to discover how Stryker is setting new standards in surgical visualization and how Stryker is collaborating with customers to create meaningful tools that improve the patient experience. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to this podcast on every major podcast platform…
1 CEO McCutcheon leaning on lessons from past successes, disappointments to move EBR Systems forward 43:00
43:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:00In this week’s podcast, we’ll visit with John McCutcheon, president and CEO of EBR Systems, which is developing a miniature pacemaker that is powered by ultrasound and located in the left ventricle of the heart. McCutcheon shares his plans for the start-up but more on the point of this week he recalls his experience as CEO of Emphasys Medical, an interventional pulmonology start-up that received a shocking negative recommendation from an FDA panel in 2008. The no vote led to the shutdown and sale of Emphasys, but the rejection ultimately helped convince the FDA and industry to assess their relationship. Ultimately, the two sides improved relations as McCutcheon explains in the podcast. The rejection is somewhat reminiscent of the negative vote issued this week by an advisory panel for Medtronic’s Symplicity Spyral renal denervation (RDN) therapy for hypertension. McCutcheon explains how the negative impact impacted him at the time, but more important how he’s moved on to appreciate the experience. Thanks for listening to the DeviceTalks Podcast Network. Subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 Abbott's Charan on AVEIR DR pacemaker's FDA approval and its potential to revolutionize cardiac care 30:45
30:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
30:45In the newest episode of AbbottTalks, Vish Charan, divisional VP of product development at Abbott, takes us through the inner workings of the recently FDA-approved AVEIR™ DR Dual Chamber Leadless Pacemaker System, from its inception to its successful clinical trial and FDA approval. Charan also dives deep into the technology, revealing the cutting-edge i2i communication technology that powers AVEIR™ pacemakers, enabling seamless communication between devices for dual chamber pacing and AV synchrony. Finally, Charan discusses the challenges of miniaturization, the remarkable advancements in battery technology that have made the AVEIR™ pacemaker possible, and the potential for further applications in conduction system pacing. As the field of cardiac rhythm management continues to evolve, Charan envisions a future of smaller devices, more features, and enhanced patient care. Make sure to listen in for invaluable insights into the groundbreaking AVEIR™ DR and its potential to transform the landscape of cardiac care. Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com. Thank you for listening to the AbbottTalks Podcast.…
1 SECRET Code Inside! Hear a replay of DeviceTalks West conversation with Intuitive’s Gary Guthart 43:56
43:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:56As a thank you for subscribing and listening to the DeviceTalks Weekly Podcast we built a special code to help you register for the Oct. 18-19 DeviceTalks West conference at the Santa Clara Convention Center. Please give a listen! Go to DeviceTalks.com to register now!! Save $300 off the full registration price. Plus, we replay our keynote interview with Intuitive CEO Gary Guthart at last year’s DeviceTalks West event. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He’ll give his assessment of the growing competition in surgical robotics and what it means for Intuitive. Finally, he shares why he thinks the term surgical robotics may have no meaning in the future.…
1 CEO Meelby Jensen on holding Ambu’s top spot in single-use scopes; Also, Why is Wall Street cranky? 49:32
49:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
49:32A little over a year after taking over the CEO role at Ambu A/S, Britt Meelby Jensen visits the DeviceTalks Weekly Podcast to draw lessons from her career that led her to lead the single-use endoscope leader last year. At the time, Meelby Jensen says Ambu was missing Wall Street expectations. In this interview, Jensen highlights the benefits of single-use endoscopes, such as improved workflow and reduced waiting times, and emphasizes Ambu's focus on sustainability. She’ll also review the company’s plan to retain its position in the white-hot single-use scope industry. But first Host Tom Salemi take a dive into earnings week with MassDevice Executive Editor Chris Newmarker and Associate Editor Sean Whooley. We won’t dig too deep into the numbers, but instead we’ll ask why Wall Street investors don’t seem too impressed with the performance of some high-flying medical device companies. Join us at DeviceTalks West on Oct. 18-19 for some in-person discussions! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.…
1 Boston Scientific executives talk urology innovation, disparities in care, and commercial strategy 55:24
55:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:24This special episode of Boston Scientific Talks brings you DeviceTalks Boston’s keynote conversation with Boston Scientific's executive leaders Meghan Scanlon, President of Urology; Jennifer Saunders, Sr. Manager of Medical Affairs; Ben Cutone, Global Franchise Director of Prostate Health; and Kristin LaRocca, Senior Vice President of Sales. In the conversation, the key figures delve into the innovative strategies and technologies shaping the urology field, highlighting the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System. They explore how Boston Scientific is addressing care disparities in underrepresented communities, pioneering programs like "close the gap" in cardiology, and advancing accessibility and equality. The conversation also highlights the importance of data-driven decision-making, clinical evidence, and humble dialogue with clinicians to commercialize innovative strategies. The panelists discuss the challenges and rewards of disrupting the market, the role of health economics, and the unique contributions of urologists as innovators. They also touch on commercial modeling and the importance of empathy, self-awareness, and courage in bringing new ideas to life. Tune in to discover how Boston Scientific is not only advancing urological care but also the way the leadership team approaches problems and solutions. Thank you to Clari for sponsoring this episode of Boston Scientific Talks. Go to Clari.com to learn about its unique revenue platform. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.…
1 What Got Steve Goetz to Join Motif Neurotech? Carmel, Jones Share Details of Upcoming MedtechVISION 1:05:02
1:05:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:02This week's episode features the first of what's sure to be many audio appearances by DeviceTalks Managing Editor Kayleen Brown! We’re also visited by Lisa Carmel and Stephanie Jone, co-chairs of MedtechWomen’s MedtechVISION conference, which is taking place on Sept. 12. They share how the conference's important agenda took shape. Go to MedtechWomen.org to register. Finally, we learn about an exciting new neuromodulation start-up called Motif Neurotech which is developing a tiny, implantable sensor that could advance how TMS therapy is delivered. Steve Goetz, a veteran of Medtronic’s neuromodulation business, explained why he left the giant to join this rising company as chief technology officer. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application!…
1 Abbott's Burton shares neuromodulation breakthroughs in diabetic peripheral neuropathy, chronic pain 59:36
59:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
59:36In the newest episode of AbbottTalks, Allen Burton, Divisional VP and Chief Medical Officer of Neuromodulation at Abbott, shares insights into the company's innovative neuromodulation therapies. Burton delves into Abbott's FDA-approved treatment for chronic back pain, which uses electrical stimulation to alleviate pain, improve functionality, and reduce reliance on opioids. Burton discusses Abbott’s recent FDA approval to treat people who suffer from back pain with limited surgical options. He also expands on how the company's pioneering treatment for painful diabetic peripheral neuropathy, a condition affecting millions of Americans. This treatment uses electrical stimulation to dampen painful signals in the feet, enabling patients to regain mobility and control over their lives. Burton further introduces the Eterna SCS System, the smallest neurostimulation system in the market, which offers patients a low charging burden and indications for MRI compatibility. Listen to the full episode to hear directly from Abbott's Neuromodulation CMO on how Abbott's patient-centric neuromodulation therapies are impacting the lives of patients suffering from chronic pain and diabetic peripheral neuropathy. Thank you to Resonant Link for sponsoring this episode of AbbottTalks. For more information about Resonant Link go to www.Resonant-Link.com. Thank you for listening to the AbbottTalks Podcast.…
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.